Medical Device ASIA, September-October 2015

Vol.7 No.5 | September-October 2015 | New Delhi

the health issue!

LIVING-DONOR Liver Transplant SIMPLIFYING Healthcare SHOW REPORT P-MEC Medical Fair Thailand Medica Connected HEALTHCARE FORUM

e d i t o r i a l

h i g h l i g h t s

Vol.7 No.5 |September-October 2015 |Annual Suscription: Rs.2,000 | Overseas: US$250

6 New devices are driving improvement in stroke treatment outcomes 7 STARLED NX series – The Next generation of LED lamps for operating room 10 High Quality Surgical Instruments 14 A Safer Hand Sanitizer with Lasting Protection!

16 CPhI & P-MEC China closes as the Chinese domestic market continues to expand 20 Precision Biosensor Overview 22 Medanta- The Medicity organised a special event on the occasion of World Heart Day 2015 25 Advanced technology used in AOH hospitals 26 Dr.Batra’s homeopathy Clinic launches 2nd clinic in Wembley, London 27 EKF’s unique and simple creamatocrit analyzer highlighted at FIGO 29 Is the Russia crisis also a crisis for medical technology?

31 ResMed launches ‘AirSenseTM 10 Autoset’ to treat Obstructive Sleep Apnea 32 Show Report: MEDICAL FAIR THAILAND 2015 36 PROFILE: Global Hospitals Mumbai 40 Living-donor liver transplant 42 MEDICA CONNECTED HEALTHCARE FORUM 45 Siemens in India 51 COMPAMED 2015: The medical technology miniaturising trend marching on – suppliers are offering solutions for various applications

MEDICA EDUCATION CONFERENCE 2015 sheds light on the future of surgery

M

edical technological systems that require medical expertise and technological know-how to be closely linked will be the primary focus at the MEDICA EDUCATION CONFERENCE, the informational platform for medicine and medical technology. It will once again be held in Düsseldorf from 16 to 19 November 2015 within the scope of the world’s largest medical trade fair, MEDICA, with around 4,800 exhibitors and recently around 130,000 specialist visitors taking part on a regular basis. This year, a day of the event will be dedicated to surgery and new operation techniques.

On 16 November 2015, the primary focus will be on innovations in the field of surgery. Within the scope of symposiums and frontal lectures on “Science and Medical Technology”, experts from the hospital, research and industrial sectors will be explaining and discussing which aids will provide support to surgeons in the operating theatre in the future. How can interventions be carried out in an even further minimally invasive manner whilst being even gentler on patients? Engineers and physicians are cooperating on a world-wide level to bring surgical systems out of laboratory and into hospitals.

The telesurgery system “MiroSurge”

One example of this includes the telesurgery system, which was developed by researchers at the German Aerospace Center (DLR) located in Oberpfaffenhofen, which will be deployable in operating theatres in a few years. A basic component of the system includes the “Miro” robotic

arm. Several of these Miro arms together with an input console with a 3D display and two tactile input devices make up the “MiroSurge” system. The surgeon controls several input arms at one time using input devices located a few metres away from the patient.

Thereby, one robot arm is equipped with a stereo HD endoscope camera that transmits video images of the patient. The other two arms are equipped with DLR instruments for working with both hands within the operating field.

These instruments are powered by electrically driven motors and sensors are located at the tips of them. The highly sophisticated integration of sensors allows direct interaction to take place between physicians, robots and patients.

This means that the sensors measure split-second interactions that take place between the tissue

within the operating field. These are passed on to physicians as a tactile experience – they feel that they are cutting into tissue.

Fascinating worlds of technology: from the conference to the specialised trade fair After a day of visiting the conference with a special theme, in the trade fair halls, participants can allow themselves to be inspired by other innovations in the field of surgery offered by respective MEDICA 2015 exhibitors. The time structure of the conference has been set up in such a way that the last events come to an end at 4:00 p.m. Afterwards, there will be the opportunity to dive into the fascinating worlds of medical technology until 6:30 p.m, when the gates to the MEDICA trade fair will be closed.

Medical Device ASIA | September-October 2015 | 3

m e d i c a l | d e v i c e s

New Rigel 288 safety analyser is a big Plus for faster medical device testing Faster and safer testing of medical devices and installed equipment in hospitals and healthcare facilities is provided by the new battery powered 288 Plus from Rigel Medical.

R

igel’s original 288 automated safety analyser now incorporates a range new features to provide enhanced performance and faster testing of electrical safety to IEC 62353 and leakage tests in accordance with IEC 61010, IEC 60601, NFPA, AAMI and AS/ NZ3551.

While most conventional testers rely on mains power, the 288 Plus retains operational integrity, even without mains connection, due to standard AA battery power compatibility.

This provides greater user flexibility and makes it quicker to complete inservice testing of point-to-point leakage as well as earth continuity and insulation resistance.

Because the new 288 Plus does not require a lengthy power cord to operate, there are no trailing cables to cause potential trip hazards, making it even safer and more convenient to set-up and use on-site. Further time saving benefits are achieved because the 288 Plus tester’s battery power back-up avoids the need for lengthy boot-up times between tests.

The Rigel 288 Plus now offers insulation testing between 50 VDC - 500 VDC to meet the test requirements of low voltage DC power supplies, 4 | September-October 2015 | Medical Device ASIA

SIARE Anaesthesia machines - AM 5000 Portable

and because it is the smallest analyser of its type, it is easier to transport from site-to-site by field engineers.

Up to 10 individual patient leakage circuits can be checked in a single test routine, while a further benefit is the ability to automatically warn users of incorrect test set-ups, helping to avoid incorrect readings – it is the only tester providing automated verification of secondary earth paths and incoming mains configuration.

The 288 Plus features Rigel’s unique earth bond technology, which combines high and low test current to ensure the accuracy of the protective earth path, helping to accurately identify any potential wear and tear. This can help to avoid the need for any unnecessary cable replacement, providing further cost savings.

An integrated keyboard enables the user to quickly input equipment details alongside electrical safety test results for improved electronic data storage and traceability. The information can be downloaded into Med-eBase – the easy-to-use test solutions software – which enables the user to trace and manage test results, setup bespoke templates, email html test certificates to clients and schedule new work orders among other customised functions.

The Rigel 288 Plus forms part of a comprehensive range of high performance specialist biomedical test equipment supplied by Rigel Medical. More at www. rigelmedical.com/288plus

The AM 5000 portable anaesthesia machine is a modular unit composed of 3 main units: a flowmeter box at 2 or 3 gases, a breathing system and a CASTOR LT trolley.

This portable anaethesia machine is suitable for use in field-hospitals, mobile units, and wherever a safe anaesthesia application is necessary.

CO2 ABSORBER FOR MANUAL / AUTOMATIC VENTILATION SEMICLOSED

The Siare CO2 absorber is a compact device for closed breathing circuit. User-friendly, it can be utilised for manual ventilation or with an automatic respirator.

The circuit is supplied with a manometer in order to read the exercise pressure, an adjustable APL valve, a selector for manual or automatic ventilation.

The soda lime jar is autoclavable and has a capacity of 2,5 kg.

More details : www.siare.it

16 – 19 NOVEMBER 2015 DÜSSELDORF GERMANY www.medica-tradefair.com

WORLD FORUM FOR MEDICINE

ays d w sho day to w e N Mon ay! m fro hursd T tion a r t egis ed! r e n r Onli is requi

BE PART OF IT!

Messe Duesseldorf India Pvt.Ltd. Centre Point 7th. Floor Junction of S.V. Road & Juhu Tara Road, Santacruz West Mumbai 400 054 Tel. (0091 22) 6678 99 33 _ Fax (0091 22) 6678 99 11 messeduesseldorf@md-india.com

New devices are driving improvement in stroke treatment outcomes

S

ince Stent Retrievers - the latest evolution of devices for IA treatment - became available in 2012, no comparative analysis with pre-retriever devices has been conducted to determine differences in utilization or clinical outcomes.

Stent is passed through an artery. The introduction of Stent Retrievers for stroke treatment has been a significant game changer;

In the last decade, Intra-Arterial (IA) stroke therapy – a technique in which thrombolytic agents and devices are passed through the arteries directly to the clot site – has

Results showed that while the number of stroke cases climbed across these three time periods, from 723,327 to 738,490, the rate of deaths decreased with newer devices.

In 2012, Stent Retrievers were associated with a mortality rate of 17.1 percent vs. pre-retriever devices in both 2008-2011 (19.3 percent) and 2006-2007 (25 percent). Additionally, the age-specific mortality following stroke intervention decreased with newer devices for patients over 80 and 65-79 years of age: 2012 (20 and 14.9 percent, respectively) compared to 2008-2011 (25.8 and 20.5 percent, respectively) and 2006-2007 (26.3 and 30.2 percent, respectively).

These findings are significant as they prove that older patients can in fact benefit from IA therapy and that age, alone, is not an exclusion criteria for interventional treatment.

treatment times, improving outcomes and

“It is clear that the introduction of Stent Retrievers for stroke treatment has been a significant game changer.

Not only have these tools provided practitioners with new approaches to treatment,” said Dr. Srikanth Boddu, lead investigator and interventional neuroradiologist at the Weill Cornell Brain and Spine Center in New York, New York, “but we have also proven that innovation is worth the investment. With treatment advances, we are seeing increasing numbers of patients survive stroke.”

decreasing mortality rates.

In a second study the usefulness and

gained notable momentum as an effective and safe treatment option for patients.

Two new studies further reinforce the value and progress of IA treatment with conclusions that the innovative new devices that facilitate this approach are reducing

6 | September-October 2015 | Medical Device ASIA

performance afforded by evolving devices were again the focus as investigators sought to understand if newer tools were associated with better outcomes and shorter procedural times. A data analysis was conducted across 6 prospective and retrospective endovascular treatment trials, with various evolutions of the Penumbra Aspiration System being used as the primary therapy.

Out of a pool of 932 subjects, study results showed that the newer and larger Penumbra catheters provided a faster and more efficient method for treating acute ischemic stroke.

In turn, when considering variables including age, baseline National Institutes of Health Stroke Scale (NIHSS) score (which assesses stroke severity), and post-treatment status of restoration of blood flow, shorter procedural times were a significant predictor of better clinical outcomes at 90 days, as measured by the modified Rankin Scale (mRS), a standard tool used to indicate level of independence following a stroke.

Dr. Donald Frei, lead author of the study, president of the Society of NeuroInterventional Surgery (SNIS) and neurointerventionalist at Swedish Medical Center, echoed the optimistic sentiment espoused by Boddu. “As each new generation of devices provides improved tools for our treatment arsenal, we are able to adjust our approach to maximize efficiencies and results for our patients. Time is the most important factor when treating a stroke, so it is incumbent upon all of us to use every tool at our disposal to achieve fast and effective treatment,” Frei said. “Thankfully, each generation of new devices has proven to reduce procedure time, which raises the chance of a successful operation.”

STARLED NX series – The Next generation of LED lamps for operating room user needs have allowed ACEM to design, develop and create its new operating lamps: STARLED3 NX, STARLED5 NX and STARLED7 NX. The whole range of STARLED NX lamps boasts a CRI value of 95, a maximum light intensity of 160.000 lux and a color temperature of 4.500°K. All these features generate a strong and cold light, ideal for the operating room.

The innovative, accurate and digital ISENSE® control panel adjusts all the functions of the three STARLED NX lamps, i.e.:

T

he light influences all the activities of the human beings. A good quality light helps to work better, decreases strain and stress as well as the error risk percentage. For this reasons, a correct illumination of the operating field is necessary for the medical staff to perform its work at best and ensure patient’s health.

The operating room needs to be equipped with a suitable lighting system according to the operating requirements to create the best working conditions.

The main target of ACEM Medical Company (Division of ACEM SpA) is just that to manufacture more and more reliable and heavy-duty products to satisfy the highest quality standards and meet the requirements both of surgeons and medical staff.

STARLED NX, the new line of surgical lamps

produced by ACEM, is realized with Next generation LED technology.

The special LED optics its lamps are supplied with, make STARLED NX series able to produce a perfect, shadow less, clear, homogenous IRfree light under every condition together with an excellent color temperature with low consumptions.

The “Made in Italy” design grants visual comfort, handiness of use and laminar flows compatibility in the operating room. The high technology used and a careful analysis of

• ON/OFF • Light intensity adjustment • SIZE – Opto-electronic adjustment of light spot diameter dimension to focus the light beam • ENDO – Light for endoscopy • DOF - Depth of field – Light in depth for a full visualization of the operating field and deep cavities • SYNC – optional mode to synchronize controls among the combined lamps according to the different configurations granting simplicity of use saving time and giving the possibility of being managed by a single operator.

ACEM SpA Medical Company Division Via della Tecnica 29 - 40050 Argelato Bologna – ITALY Ph +39 051 721844 Fax +39 051 721855 info@acem.it www.acem.it

Medical Device Asia | September-October 2015 | 7

3-D printing techniques help surgeons carve new ears week at the American Academy of Otolaryngology - Head and Neck Surgery conference in Dallas.

“It’s a huge advantage over what we’re using today,” said lead author Angelique Berens, a UW School of Medicine otolaryngology - head and neck surgery resident. “You literally take a bar of Lever 2000 while the attending is operating and you carve ear cartilage. It does teach you how to get the shape right, but the properties are not super accurate you can’t bend it, and sewing it is not very lifelike.”

In the study, experienced surgeons preferred carving the UW’s models (in white) over a more expensive material made of dental impression material (in blue); © University of Washington

When surgical residents need to practice a complicated procedure to fashion a new ear for children without one, they typically get a bar of soap, carrot or an apple.

T

o treat children with a missing or under-developed ear, experienced surgeons harvest pieces of rib cartilage from the child and carve them into the framework of a new ear. They take only as much of that precious cartilage as they need.

That leaves medical residents without an authentic material to practice on, as vegetables are a pale substitute. Some use pig or adult cadaver ribs, but children’s ribs are a different size and consistency.

Now, a collaboration between a University of Washington otolaryngology resident and bioengineering student has used 3-D printing to create a low-cost pediatric rib cartilage model that more closely resembles the feel of real cartilage and allows for realistic surgical practice. The innovation could open the door for aspiring surgeons to become proficient in the sought-after but challenging procedure.

Their results are described in an abstract presented this 8 | September-October 2015 | Medical Device ASIA

As part of the study, three experienced surgeons practiced carving, bending and suturing the UW team’s silicone models, which were produced from a 3-D printed mold modeled from a CT scan of an 8-year-old patient. They compared their firmness, feel and suturing quality to real rib cartilage, as well as a more expensive material made out of dental impression material.

All three surgeons preferred the UW models, and all recommended introducing them as a training tool for surgeons and surgeons-intraining.

Kathleen Sie, a UW Medicine professor of otolaryngology - head and neck surgery and director of the Childhood Communication Center at Seattle Children’s, said the lack of adequate training models makes it difficult for people to become comfortable performing the delicate and technical procedure, which is called auricular reconstruction.

There’s typically a six- to 12-month waiting list for children to have the procedure done at Seattle Children’s, she said.

“It’s a surgery that more people could do, but this is often the single biggest roadblock,” Sie said.

“They’re hesitant to start because they’ve never carved an ear before.

As many potatoes and apples as I’ve carved, it’s still not the same.”

Another advantage is that because the UW models are printed from a CT scan, they mimic an individual’s unique anatomy. That offers the opportunity for even an experienced surgeon to practice a particular or tricky surgery ahead of time on a patient-specific rib model.

Co-author Sharon Newman, who graduated from the UW with a bioengineering degree in June, teamed up with Berens while they both worked in the UW BioRobotics Lab under electrical engineering professor Blake Hannaford.

Newman figured out how to upload and process a CT scan through a series of free, open-source modeling and imaging programs, and ultimately use a 3-D printer to print a negative mold of a patient’s ribs.

Newman had previously tested different combinations of silicone, corn starch, mineral oil and glycerin to replicate human tissue that the lab’s surgical robot could manipulate.

She poured them into the molds and let them cure to see which mixture most closely resembled rib cartilage.

“I would go to the craft store and Home Depot and say I want to make models - what aisle should I go to?” said Newman. “It turns out a lot of these ideas were based off of materials people use for arts and crafts like rings or other jewelry.”

The team’s next steps are to get the models into the hands of surgeons and surgeons-in-training, and hopefully to demonstrate that more lifelike practice models can elevate their skills and abilities.

High Quality Surgical Instruments from Germany

W

e are a competent, globally established partner for surgical instruments.

Through our trading partners, we export our goods worldwide to currently 60 countries.

Our claim:

Products predominantly manufactured in Tuttlingen provide the basis for premium quality. Thanks to our corporate structure, one of our strengths is outstanding value for money.

Our philosophy:

The technical competence of our staff, based on years of experience in medical technology, guarantees our customers comprehensive and reliable service. We combine an extensive product range with top rate individual advice and support all the way through to timely delivery.

Our product range:

Over 22,000 articles cover the entire spectrum from general surgery to specialised disciplines extending to the supply and disposal of sterile products.

Using glass bead blasting, our surgical instruments are supplied with an especially non-dazzling surface.

For more information: AS Medizintechnik GmbH Sattlerstrasse 15 / 78532 Tuttlingen Phone:+49 7461 96632-77 Fax: +49 7461 96632-88 E-Mail: Lars.Doering@ASMedizintechnik.de Internet: www.AS-Medizintechnik.de

Fighting fakes with the first integral 3-D barcode The first 3D barcode which can be built into products during manufacture has been developed by UK engineers.

The anti-counterfeit marker is virtually invisible to the naked eye and impossible to detect by touch. It can be read using a laser scanner, allowing anything from phones to pills to be tracked and verified as authentic.

Made public at the British Science Festival in Bradford, UK, the technology was devised by the UK SME, Sofmat Ltd, and has been developed in collaboration with engineers from the University of Bradford.

The 3D barcode is made up of tiny indentations in the surface of the product, created by pins which are integrated into its mould. Using micro actuators, the pins can be set at different heights, each step corresponding to either a letter (A-Z) or a number (0-9).

The prototype - developed with funding from Innovate UK - works with a four pin array, enabling over 1.7 million different configurations.

“The system enables very small displacements to be made in each pin each step being just 0.4microns, 100th of the width of a human hair,” explains Dr Ben Whiteside, from the University of Bradford. “These have to be set with a very high accuracy, and with sufficient force so their position is maintained during the manufacturing process. While our system has been developed initially for products made from plastics or composites through injection moulding, it could also be used to stamp or emboss the code onto a product.”

Estimates for the total value of fakes sold worldwide each year reach as high as $1.8 trillion. Most anti-counterfeit devices are stuck onto the product or its packaging after manufacture, making them easy to copy. Because the 3D barcode is an integral part of the product itself it is very difficult to reproduce.

“A 3D barcode allows much more complexity than existing anti-counterfeit systems,” explains Sofmat Director Dr Phil Harrison.

10 | September-October 2015 | Medical Device ASIA

Company Profile CapitalBio Technology distributors and dealers worldwide.

It has offices in Hong Kong and the USA and its products have entered the clinical and research markets in more than 20 countries.

Located in northwest Beijing since the year 2000, CapitalBio Corporation is a leading provider of life science solutions. It consists of four research institutes and five subsidiaries. The four research institutes are: Research Institute of Translational Medicine, Research Institute of Bioinformatics, Research Institute of Engineering and Research Institute of Health Science. The five subsidiaries are: CapitalBio Technology Co., Ltd., CapitalBio Diagnostic Laboratory, CapitalBio eHealth Science & Technology (Beijing) Co., Ltd., CapitalBio Genomics Co., Ltd. and CapitalBio New View Diagnostic Technology Co.,Ltd.

C

apitalBio Corporation provides a comprehensive product range to a wide spectrum of endusers; from biomedical researchers to health care professionals. These products include; biochips and related instrumentation, software and databases, reagents and consumables for applications in drug development, clinical diagnostics and bio-safety testing.

12 | September-October 2015 | Medical Device ASIA

CapitalBio Corporation’s kits can diagnose a wide range of diseases such as deafness gene mutations, Tuberculosis related diseases, HPV related diseases, Thalassemia gene mutations, HBV drug resistance and Respiratory Pathogens Nucleic Acid Detection. CapitalBio Corporation also undertakes a wide range of sequencing services.

CapitalBio Corporation has 65,000 m2 research and production facilities, which are ISO 9001 and ISO 13485 certified. Its products are certified with appropriate China FDA, CE and TUV/GS Certificates and clinical certificates in other countries. Its HLA Genotyping Lab is ASHI certified (since 2015). CapitalBio Corporation has established strategic partnerships with many life science companies around the world, as well as with

Innovation drives CapitalBio Corporation’s continuous growth in the Life Science technology field. CapitalBio Corporation also develops various cutting-edge biochips utilizing microfluidic technology, microprocessor technology and bio-electro-magnetic technology. Up to now, it has filed over 200 patent applications, the majority of which have already been issued. CapitalBio Corporation has built a strong reputation for R & D of biochip related instruments and its products have been awarded numerous prizes.

CapitalBio Corporation warmly encourages discussions of new business, marketing and production opportunities. It is seeking to reduce the cost of products to benefit its customers through innovation and a commitment to rapid product development. It is open to collaborations with overseas partners to pursue joint development and commercialization of advanced research and diagnostic products and tools, and to leverage its R&D, production and commercialization capabilities.

A Safer Hand Sanitizer with Lasting Protection!

Klenza – India’s only Silver Enriched Alcohol Free Hand Sanitizer with 3 Hour Germ Protection Always know your hand sanitizer! Most conventional hand sanitizers are alcohol based and stop working the moment you touch something.

But here’s an interesting revelation. Recently launched Klenza, is one of its kind foam based, alcohol free hand sanitizer with a Pure Silver based formulation that is tested as per international standards. Made using a patent pending silver based technology, Klenza actively shields your hands with 99.999% protection against germs. What is more, the natural goodness of the Pure Silver formulation provides continued three hour protection, thus ensuring lasting resistance from germs.

Being an alcohol free sanitizer, Klenza is a non-toxic and non-flammable green product that doesn’t use any harmful ingredients like triclosan or paraben etc. Formulated using natural ingredients, this sanitizer can be used at all times without any harmful side effects.

Exceptionally gentle and safe on all skin types including kids (3+ years).

Unlike conventional alcohol based sanitizers, Klenza does not dry out the skin but instead keeps hands moisturized. Its distinctive foam dispenser pumps small quantities for easier and smoother application.

Klenza sanitizers are much safer and ensure 3 hour continued germ

protection, making Klenza the best of its kind hand sanitizer.

Available in two exquisite fragrances Cool Cologne and Smooth Strawberry, Klenza comes in the 200ml foam pump for Rs. 198 with 250 applications and the 50ml foam pump for Rs. 90 with 120 applications.

Klenza hand sanitizers are available in select stores and malls across Bangalore. You can also buy it online at stores like Flipkart, Amazon, FirstCry, PayTm etc.

Read more - www.klenza.in, www. facebook.com/klenzacare About Resil Chemicals Pvt Ltd: Resil Chemicals Private Limited is a pioneer of silicone formulations for textile finishing in India and one of Asia’s largest formulators of customized silicones for textile and non-textile applications. Since its inception in 1994, the company has diversified its product range to include specialty chemicals for textile and non-textile applications, emerging technology based products such as hand sanitizers, disinfectants and products for automobile detailing.

Today Resil employs more than 300 people and has offices across Asia in India, Thailand, Myanmar, Bangladesh and Sri Lanka. The Company which was founded in Bangalore, India, has grown to meet the technical and scientific requirements of the global market, helping customers to move forward.

Resil’s vision is to be an organization that delivers optimum value and satisfaction to all stakeholders and the community at large. The company ensures that the offered products & services are aimed at improving health or user comfort and lifestyle aspirations of the society it serves with adequate environmental care.

14 | September-October 2015 | Medical Device ASIA

High-volume facilities better for nursing hip fractures A potentially useful quality indicator about nursing facilities is the number of hip fracture patients during the prior year There is not a lot of information available to help family caregivers choose the best skilled nursing facility for an elderly loved one who breaks a hip, but a new study suggests a potentially useful quality indicator: the facility’s number of hip fracture patients during the prior year.

The sweeping new analysis shows that the most experienced skilled nursing facilities were more than twice as likely as the least experienced to successfully discharge patients back to the community within 30 days of breaking a hip. The results, led by Brown University researchers, appear in the Journal of the American Geriatrics Society.

“While volume is not a direct measure of post-acute care quality, it appears that it is a good proxy that captures hard-to-measure aspects of quality, like the expertise of the staff, that are clearly associated with an outcome that patients care about: returning home soon and in a condition that allows them to remain at home without further institutionalization in a hospital or a nursing home,” said lead author Pedro Gozalo, associate professor (research) of health services, policy and practice in the Brown University School of Public Health.

Gozalo and his colleagues reviewed records of more than 512,000 patients age 75 and older who sought care at more than 15,400 skilled nursing facilities between 2000 and 2007. The researchers measured the volume of cases at each of the facilities in the 12 months leading up to each admission and noted whether the patient was discharged to the community within 30 days.

In all, about 31 percent of people were able to return home within a month, but that rate varied widely among facilities of different experience. The rate of successful discharge from facilities with more than 24 cases in the prior year was 43.7 percent, but it was only 18.8 percent at facilities with one to six cases a year.

To check whether this could be for some reason other than volume, Gozalo and his colleagues statistically accounted for a large number of attributes of the patients and of the facilities, such a nurse and therapist staffing levels.

“Even adjusting for a long list of patient risk factors and for important facility characteristics, facilities that had cared for more than two dozen hip fracture patients in the last 12 months were more than twice as likely to successfully discharge patients in a timely manner compared to facilities that had three or less hip fracture admissions,” Gozalo said.

The study also revealed that many patients are not going to higher-volume facilities, even though they could. According to the records, more than 70 percent of people who went to a lower-volume facility could have found a higher-volume facility within 10 miles.

That finding, Gozalo said, suggests that people do not have much information about quality. The Centers for Medicare and Medicaid Services make some information available, but that can be hard for many families to access and interpret. Hospital discharge planners also vary widely in what information they provide to families.

“Based on our results, it would seem that in addition to any other sources of information and recommendations the family can get, they should definitely ask each facility they are considering what was the number of hip fractures they cared for in the last year,” Gozalo said. “It is a basic but very informative predictor of how well their loved one may fare at that facility.”

COMPANY PROFILE | Baige Medical

operating room; Intelligent breathing circuit: autoclavable, integrated, overall heating, convenient for soda lime canister change; Powerful ventilation function: minimum tidal volume to 15ml, full ventilation modes with manual, VCV, P-mode, PCV, PSV, SIMV-VC/PC, PRVC; CE mark with same brand Vaporizers.

A sound distribution and service network has been being formed and extended to the world.

Baige Anesthesia machines, intimately complied with clinical demands, ELUNA series and CENAR series adopt advanced design concept, powerful ventilation function, high quality ventilation comparable with ICU ventilator, complete monitoring parameters as well as intelligent breathing circuit, contributing safe clinical anesthesia. The various options offer doctors flexible choices to meet different requirements: Ergonomic design: • touch screen, easily and friendly operation; • compact and concise, suitable for the crowded operating room;

Baige Medical is a professional high-tech manufacture of respiratory and anesthetic products, founded with the goal of delivering high-quality and competitive medical devices around the world, making healthcare friendlier and easier.

Baige Medical has a strong and outstanding R&D team, which consists of experienced engineers and experts from medical area. All the products (anesthesia machine, anesthetic vaporizer) have received CE mark and ISO 13485, ISO 9001 certificates from TUV. Baige Anesthesia machines, intimately complied with clinical demands, ELUNA series and CENAR series adopt advanced design concept, powerful ventilation function, high quality ventilation comparable with ICU ventilator, complete monitoring parameters as well as intelligent breathing circuit, contributing safe clinical anesthesia. The various options offer doctors flexible choices to meet different requirements: Ergonomic design: touch screen, integrated suitable for the crowded

Intelligent breathing circuit: • Highly integrated, suitable for low-flow anesthesia; • Overall heating design, reducing condensate water; • Autoclavable, avoiding cross-infection; • Bypass switch convenient for exchanging Soda Lime canister during operation; • Auto prompt of circuit status, avoiding imperfect installation of Soda lime canister.

Powerful ventilation function: • Minimum tidal volume to 15ml; • Full ventilation modes: manual, VCV, P-mode, PCV, PSV, SIMV-VC/PC, PRVC; • 0Perfect tidal volume compensation: real-time dynamic compensation and compliance compensation.

Accurate Vaporizers: • High quality with CE mark • Superb Performance, particularly at low flows • Enflurane, Isoflurane, Sevoflurane Medical Device ASIA | September-October 2015 | 15

CPhI & P-MEC China closes as the Chinese domestic market continues to expand International companies looking to gain a foothold in this lucrative and gentrifying pharma economy CPhI & P-MEC China, hosted by UBM EMEA and CCCMHPIE, and co-organised by UBM Sinoexpo held its most successful event yet at the Shanghai New International Expo Centre, (SNIEC) 24-26 June 2015.

T

his year marked the 15th anniversary of CPhI China, and a decade in partnership with P-MEC. Over the past 10+ years, this event has successfully grown in lieu with the rapidly expanding Chinese market, acting as a central hub for crucial networking and knowledge sharing opportunities – CPhI and the pharma industry in China are inseparable drivers of each other’s development.

As discussed, in the impending CPhI Insights Report on the Chinese

market (to be released next week), unlike pharma manufacturing in the West, China’s growth is not solely dependent on increasing sales of finished formulations in highly regulated markets – the economic and cost advantages from large scale API batches are simply too strong to be resisted.

The increased interest in this market was reflected at the event, which delivered record numbers in both event scale and attendance for 2015. Over 2,600 global companies

16 | September-October 2015 | Medical Device ASIA

exhibited across the 150,000 square metre floor space and 64,000+ visitors were welcomed to CPhI & P-MEC China and concurrent event Fi Asia China (FiAC).

Over 80 onsite conferences and activities were hosted, covering numerous pressing topics ranging from contract services to environmental protection and clean technology. In particular, the ‘2nd P-MEC Summit’ and ‘International Summit for Pharmaceutical Packaging & Drug Delivery System’ achieved remarkable results and highlighted the important role P-MEC and Innopack China play in the industry.

The huge portfolio of content,

exhibition halls and industry executives signifies why CPhI & P-MEC China is such a crucial event to the pharmaceutical industry. Jie Wang, Vice President at Zhejiang Huahai Pharmaceutical Co., Ltd, comments: “The main benefit for us is being able to meet with all the clients and suppliers at the same time. CPhI holds a unique advantage by being the perfect one stop of all our needs.”

As China’s domestic market continues to expand, CPhI & P-MEC China will increasingly update its offering and retain its vital stance as a must-attend event for industry executives from all over the world.

“After CPhI Worldwide, China is the longest running CPhI event and the second largest. With consistent, strong growth forecast for the China pharma market over the next decade, CPhI & P-MEC China remains as crucial as ever in providing an international platform for global pharma executives, manufacturers and suppliers to meet. The key to success for most international manufacturers operating in China is partnering with the right local

company and acquiring local knowledge – CPhI is integral to this.

The past 15 years have brought concurrent progress to the event and wider industry and UBM EMEA will continue to uphold the trust of the industry as we look forward to the next 15 years with immutable enthusiasm.” Chris Kilbee, Group Director Pharma, UBM EMEA.

Medical Device ASIA | September-October 2015 | 17

Perry Baromedical Sigma Series Hyperbaric Chambers

Perry Baromedical Corporation has been the leader in the field of Hyperbaric Oxygen Therapy (HBOT) for more than 40 years. Based in Riviera Beach, Florida, it is a privately held company with a history of industry-wide innovation and quality which dates back to its founding as a submarine builder in 1956. Perry manufactures the world’s finest series of hyperbaric oxygen chambers, including the Sigma 34, 36, 40 & 40-II models. It has an unmatched record in safety and quality with the US FDA, and the largest and most comfortable monoplace and dualplace hyperbaric chambers in each size category. Recent product innovations include the Sigma Elite & EMR (Electronic Medical Record) computerized chamber with wound database integration capability; the Sigma 40-II - the world’s first fulllength acrylic dual-place HBO chamber; and the addition of in-house clinical education and turnkey O2/Air plant project design and delivery services.

Backed by Perry’s superb track record in service, overall manufacturing quality and safety, as well as its multi-national sales and service team, Perry is introducing its HBO chambers through a network of highly qualified turnkey project partners in Asia, and has regional projects operating or underway in Taiwan, Vietnam, Bangladesh, the Philippines, India, Australia and Thailand.

Perry has manufactured over 1,000 hyperbaric systems, with over 4.5 Million safely completed treatments, and an installed based spanning more than 30 countries. With advanced technological expertise including proprietary 100% optically pure acrylic manufacturing and the most functionally versatile and robust software engineering design, Perry’s mission is to continually innovate and deliver the finest Hyperbaric Oxygen Chambers worldwide. www.perrybaromedical.com or call 1-800741-4376.

18 | September-October 2015 | Medical Device ASIA

COMPANY|PROFILE

Vermeiren Medical Equipment Co., Ltd.

Vermeiren Medical Equipment Co., Ltd. is a professional medical equipment manufacturer from Belgium. Over the last half century, Vermeiren has been working at the production and innovation of wheelchairs, beds and other home care products.

The quality and sales volume of Vermeiren products rank the 3rd in Europe and the 4th over the world. Vermeiren enjoys a worldwide popularity with her first-class quality, advanced technology, courtesy service and warm care. After fifty years’ development, Vermeiren Group has founded subsidiaries across Europe (including Belgium, Germany, Holland, Switzerland, France, Italy, Austria, Poland, Spain and Czech). In 2005, a new production facility was built in Suzhou of China to supply products to Europe as well as other parts of the world.

Medical Device ASIA | September-October 2015 | 19

Precision Biosensor Overview Precision Biosensor was founded in 2009 as a venture company on Daedeok INNOPOLIS high-tech research cluster in Daejeon, South Korea.

We focus on the development and manufacture of high quality rapid immuno-diagnostic products to serve the point-of-care market place including medical professionals, physicians, clinical laboratories and hospitals.

P

recision Biosensor specializes in rapid POCT immunoassays for the detection of cardiac markers, inflammation and drugs of abuse etc. in the emergency department. Precision Biosensor’s key workforce has extensive experience in the IVD industry and utilizes their experience to satisfy customer needs by ensuring the highest level of product quality.

Precision Biosensor’s experts keep optimal quality control to provide high quality biochemical regents.

We proud to be among the few that have a track record for successfully developing test devices through the development of raw materials and obtaining US FDA and CE clearance. Precision Biosensor’s unique techniques have enabled us to rapidly develop all classes of monoclonal antibodies for each of the illicit drugs and cardiac disease markers to be specifically used for the rapid assay.

For deliver high accuracy, high reliable and affordable point-of-care and diagnostic solutions to customers, Precision Biosensor strives to improve measurement systems technologies. With more than 10 years’ experiences in the field of tera-hertz photon detection and measurement, our engineering physicists has developed a series high performance In-Vitro Diagnostics Readers provide qualitative and quantitative analysis for immediate Point-of-care Testing (POCT) with high accuracy and sensitivity such as colloidal gold reader, TRF (Time Resolved Florescence) strip reader, TRF imaging system, high efficiency concentrated photovoltaic(CPV) module based on its unique TRF readout and light guide solutions for imaging and light concentration, as well as pyro-electric detector. In-Vitro Diagnostics Reader provides a new multi analysis platform for the growing IVD market. Our diagnostic device systems can be applied to various immunoassays used today requiring highly sensitive and accurate standard.

In order to create more value, all members of Precision Biosensor are working hard, and trying to be the world leader in this field. Final goal of our company is to contributing to make our life a little better than today.

20 | September-October 2015 | Medical Device ASIA

Products

In-Vitro Diagnostics Reader: Provide quantitative analysis for immediate point-of-care Testing (POCT) with high accuracy and sensitivity. The Readers can achieve automatic detection of Cardiovascular Disease, Infectious Disease, Drugs of Abuse Test and other Health Test for emergency department such as ICU, CCU, Emergency Room, Physician Office etc.

Rapid Diagnostics Test: - Cardiovascular Disease Test : AMI 3 in 1, 2 in 1, TnI, NT-proBNP, D-dimer and hs-CRP - Infection Related Test : CRP, PCT - Others : DAT Test, Nicotine Test

Service

With extensive tera-hertz photon detection and measurement development experience, Precision Biosensor provides comprehensive service solutions to partners including OEM/ODM service, proprietary software design, technical support, training and upgrade.

For more details, please contact: Precision Biosensor Inc. 100 Shinsung-Dong, Yuseong-Gu, Daejeon, Korea 305-804 T: +82-42-867-6300 F: +82-42-867-6302 E-mail: jwkang@terawave.co.kr Web: www.terawave.co.kr

Full body photon therapy presented

by H. Buschkühl GmbH at

Medical Fair Thailand 2015

Netturul Resources Sdn Bhd Profile & Background Netturul Resources Sdn Bhd started operations on 15 January 2011. The nature of the business is in direct distribution of weight plan product (Cambridge Weight Plan “formerly known as The Cambridge Diet” originated from United Kingdom).

This company holds the exclusive sole distributorship of the brand in Malaysia, Singapore, Indonesia & Brunei.

Netturul Resources Sdn Bhd is also the authorized training centre appointed by Cambridge Weight Plan Ltd in United Kingdom.

H. Buschkühl GmbH presented its awarded full body photon therapy which is in use in Europe and many other countries as general therapy system. The Bionic 880 offers 4 therapy modes and it is in use by all medicine discipline: Local mode: Pain relief, wound healing, inflamation, burnings Fractures a.o.

Harmonizing of hormons

Endorphine, cortisol, serotonin, melatonin, dhea This allows a wide range of treatment possibility and the use by all medicine discipline.

Cambridge Weight Plan is a product that needs consultation. The weight management consultants appointed have undergone comprehensive trainings locally as well as in United Kingdom to be accredited as qualified consultants.

Cambridge Weight Plan is an evidence based weight management plan makes use of specifically formulated flavoured shakes, soups, bars and porridge to supply low calorie diet ranging from about 440 – 1500 calories per day.

It contains the necessary vitamins, minerals and trace elements that the body needs to maintain balanced nutrition, can be used on for fast weight loss or with normal meals for a more gradual weight loss or for weight maintenance.

New for the Asia.

• Treatment of bacteria diseases without using antibiotics • Treatment of viral diseases.

All treatments does not know any side effects. For patient most interesting the treatment of bacteria diseases without using antibiotics with a success quote over 90%.

Many visitors showed interest in the new Health Scanner which scans a person within 1 minute and offers over 200 reports. This system finds interest by doctors, pharmacists, Anti aging and wellness institutes, Gym and sport clubs.” We hope for a good after show business” said the CEO Dr. h.c. Buschkühl.

Cambridge Weight Plan formulation has been proven to be safe and effective for weight management and weight maintenance. Evidence based Gold Standard Research papers have been published in BMJ, IASO, Clinical Obesity to name a few.

Cambridge Weight Plan is The global brand-leader in evidence-based weight loss with formula diet . Safe - Effective - Complete Nutrition • Prediabetes • Diabetes • Sleep apnoea • Osteoarthritis • Weight loss before surgery • Other weight related problems Since 1980s, millions of people around the world have successful lost weight and kept it off with Cambridge. Cambridge Weight Plan is an evidence-based weight loss and maintenance programme with sustained health benefits. For success stories , please log into http://www.cambridgeweightplan.com/ success-stories Medical Device ASIA | September-October 2015 | 21

Medanta- The Medicity organised a special event on the occasion of World Heart Day 2015 Renowned heart surgeon, Dr. Naresh Trehan’s Medanta – The Medicity today organised a special event on the occasion of World Heart Day 2015. As a part of the event, Dr. Trehan addressed distinguished guests and Gurgaon residents on the grave situation of heart diseases in India and advised on their prevention and leading a healthy life.

Dr. Naresh Trehan said, “India is quickly becoming a heart-disease epicentre due to a mix of genetic predispositions, diet and lifestyle factors. An estimated 6 Crore Indians are suffering from heart diseases. We consume more food than necessary which is high in calories and engage in ever lesser physical activity. We are addicted to sugar and are afflicted with stress. It is time for us to take a step towards a generation free of heart diseases. This World Heart Day beat together against the spread of this preventable epidemic.”

NEU Industries offers wide range of Infection Control product, Surgical Instrument Re-processing system and consumables for Hospitals and Nursing homes.

Infection Control Equipment

DDC Dolphin macerators for disposal of single-use bedpan/urinal pulps Single-use bedpan/urinal pulps Hard surface and hand sanitizers that kills 99.999% bacterial Electric/hydraulic stretchers, chairs and recliners Sterilization Department

Sealer and automatic pouchmaking machines Washer Disinfectors and Bedpan sanitizers Steam Sterilizers and Autoclaves Detergent for manual/automatic washing of instruments Soil indicators for washers/sterilizers Surgical Instrument and Tracking System

General/specialised surgical instruments with RFID option Software to track/manage surgical instrument within and outside various hospitals

22 | September-October 2015 | Medical Device ASIA

Medanta also organised a free health camp on the sidelines of the event which was attended by more than 500 residents.

It is being predicted that in the next few years India will the World capital to Cardiovascular diseases.

Talking on preventing heart diseases, Dr.RR Kasliwal(Chairman of Clinical & Preventive Cardiology, at the Medanta-The Medicity) said “Our young South Asian population will bear 60% of the world’s heart disease burden.

We would perhaps do well in celebrating World heart decade instead of just a World Heart Day. Avoid the “Six Ss” that is, smoking, sedentary lifestyle, salt, sugar, stress and saturated fats to stay heart-healthy. A cardiovascular diseasefree India is possible if only we can put our hearts to preventing it.”

About Medanta:

Medanta – The Medicity is one of India’s largest multi-super specialty institutes located in Gurgaon, a bustling town in the National Capital Region.

Founded by eminent cardiac surgeon, Dr. Naresh Trehan, the institution has been envisioned with the aim of bringing to India the highest standards of medical care along with clinical research, education and training. Medanta is governed under the guiding principles of providing medical services to patients with care, compassion, commitment.

Spread across 43 acres, the institute includes a research centre, medical and nursing school. It has 1250 beds and over 350 critical care beds with 45 operation theatres catering to over 20 specialties. Medanta houses six centres of excellence which will provide medical intelligentsia, cutting-edge technology and state- of-the-art infrastructure with a well-integrated and comprehensive information system.

INDIA’S ONLY HOLISTIC MOBILE WELLNESS APP, LAUNCHED

BODY CARE – AN APP FOR PREVENTIVE CURE ON iOS & ANDROID and guide on the subject for anyone who has a smart phone. The content is dynamically updated and will stream around two hundred videos per day in all different categories,” he adds.

In the last seven years of its existence, Care World TV as a medium has contributed much to the development and progress of this industry. Bridging the gap between the functionary and the beneficiary, Care World TV today is the epitome of health and wellness.

Care World TV - the first and largest healthcare satellite channel in Asia has announced the launch of its wellness mobile app ‘Body Care’. The app will give users access to unlimited videos on various wellness aspects ranging from beauty to diet, fitness to sex and yoga to astrology.

Besides this, the app incorporates a personalised interactive feature that allows users to direct queries to Subject Matter Experts (SME)s and doctors to receive one-on-one consultation. The app interface is userfriendly and is available on both iOS and Android platforms. The app has been built with the dual intent of accessibility and privacy.

“

The health and wellness industry in India is embarking upon a new era of preventive wellness, as against curative wellness. Taking cue of the trend, we at Care World have yet again taken the lead in making available the resources into people’s hands, quite literally,” says Mr. Ajit Gupta, Managing Director, Care World TV. “With an inventory of over thirty thousand videos covering all aspects of wellness, delivered by experts from around the world, the app is a complete knowledge bank

“Data suggests that online users in India, not just urban but also rural, access internet on their phones more than on other devices. Considering this, we wanted to reach out to a larger audience and an app works as the ideal solution. All video content on Body Care is HD quality and despite being in HD, one will not experience any buffering in the streaming. Each video clip may range between three and ten minutes with information that is clear, concise and comprehensive,” says Mr. Ashok Singh, Creative Head, Care World TV. Today, contemporary media is omnipresent and becoming available on mobile apps has been the latest addition. However barring popular media, there are very few channels that air niche content which have taken lead in launching a mobile app.

In the health and wellness domain, Care World TV has become the first to do so and has already gained tremendous response for its mobile app - Body Care.

“Over the last one decade, the health and wellness industry has come a long way in educating and familiarizing Indian audiences with the concept of wellness. We are proud to have played the role of torch bearers and pioneered the concept of wellness, ahead of its time. Today, we are happy that new players are joining the fraternity and are planning on launching wellness channels. This only indicates that the industry has evolved and is ready to move into the next phase of its growth. So, the launch of our wellness app comes at a great time and we are positive that it will create a new benchmark and which will be followed by many,” concludes Mr. Gupta.

About Care World TV: CARE WORLD TV, Asia’s only Satellite healthcare TV Channel, emerged as the need of the hour by fulfilling a vacant niche, has successfully completed 7 years of disseminating health related information to the masses thus bridging the gap between the functionary and the beneficiary. Keeping in tune with the boom in the healthcare Industry with constant changes, in trends, development, research, the channel has introduced various innovative shows with exclusive content. The content is produced in its Mumbai involving experts from the industry has generated viewers in India, Bangkok, Pakistan, Nepal and many more Asian countries. Care World is available on all major Cable Networks across the country and also can be accessed on Videocon DTH.

Medical Device ASIA | September-October 2015 | 23

Roal Electronics SpA, will be presenting the DDP600 series of extremely compact, efficient, 600 Watts AC-DC power supplies.

Roal Electronics SpA will be presenting its DDP600 series of extremely compact and efficient ac-dc power supplies at Compamed 2015 , Hall 08B, Booth 8BK31 at D체sseldorf, this November.

T

he series provide a steady 600 W of regulated DC power, through the full 85 to 305 VAC input range, in a 4.4 x 7.3 x 1.6 inches form factor. It will be presented in two different packages: enclosed, with a built in fan cooling solution, and in a U-shaped chassis. Further variants, part of the product range, will be released to meet the system integrators demands.

The new DDP600 series, has been specifically designed to meet the widest application requirements in the Industrial, Medical and SSL market segments. Offering 600 Watts at 24,36 and 48 VDC single output voltage, the series keep unchanged all functional parameters throughout the 85 - 305VAC extended range of input voltages.

A 94% typical efficiency, 2 x MoPP medical protection grade, a greater than 0.9 PFC at any working condition and a 800 Watts peak power for 10 seconds, are the DDP600 series key characteristics.

24 | September-October 2015 | Medical Device ASIA

By converting energy to typically 94% efficiency, the DDP600 series generate less heat thus facilitating thermal management in space constrained systems and offering higher reliability.

The DDP600 series current release, come with two standard 24, 28, 36 and 48VDC output voltages, offer a 12VDC auxiliary and +5VDC standby outputs. Available control signals include Power Good and Remote On/off.

The series feature a built in I-share circuitry for parallel operation between power units to enhance total power and, adding a FET-based OR-ing external circuitry, offered as optional, allow N+1 redundant operation.

The enclosed units can deliver full output power from -20 to 50째C and can operate up to 70째C with de-rating. All versions are capable to start up from -20째C. A built-in fan speed control circuit does assure a proper forced air cooling flow in every working

condition minimizing operation noise and enhancing useful life.

Protection features include HighBreaking capacity fuse on both Line and Neutral, input under voltage lockout (IUV), output over-current (OC), output short-circuit (SC), output over-voltage (OV) and overtemperature (OT).

ROAL Electronics will present the DDP600 series of power at Compamed (Hall 8b, Booth K31) this November as additional confirmation of its innovative design skills and valuable long experience capable to translate company talent and competencies into cost effective solutions which, while suitable for the most diverse applications, still represents the excellence in terms of power density and efficiency.

The DDP600 family comply with the 3rd edition of the IEC 606011 safety standard for medical equipment offering 2x MoPP protection grade and being suitable for BF rated applied parts. The series comply also with the 2nd edition of the IEC 60950-1 standard for IT equipment and UL8750 for lighting applications. The series meets the EN55022 EMC limits of Class B for conducted and radiated emissions as well as the IEC/EN 61000-3 and IEC/EN 61000-4 EMC standards.

For additional details about Roal Electronics SpA and the new DDP600 series of ac-dc power supplies, visit www.roallivingenergy. com, or e-mail at sales.roal@ roallivingenergy.com.

Advanced technology used in AOH hospitals

Association of Hospitals (AOH), one of the oldest and trusted associations in healthcare of Mumbai uses advance technology for all the classes of society.

AOH believes in using advanced technology and upgraded healthcare delivery quotient of Mumbai. Apart from the routine medical equipment, these hospitals also have highly specialized, modern equipment and perhaps the first in India.

AOH

has inducted some of modern equipment such as Digital X-Ray System (YSIO), Digital Fluroscopy System and Tomogram & Ultra Sound System. For convenience of the patients, multiple ultrasound sonography & CT machines are set up in multiple hospitals. Modern BMD System that detects osteoporosis, 3-room Intra-operative Magnetic Resonance Imaging System (IMRIS) are highly used for surgical or interventional procedures.

Highly developed equipments like SKYRA, a high-tech unit is the most recent 3 tesla with 64 Channel MR Imaging systems with advance technology for neurological functioning, Laser technologies for Urology that helps in lithotripsy systems for treating kidney & prostrate illness, CRRT machine dedicated in house RO Plant to cater dialysis treatment, and Ophthalmology department.

High-tech services such as ICUs’ equipped with positive and negative isolation rooms for tranquil efficiency, Wireless monitoring during emergencies, Rehabilitation Care inclusive of Aquasice for Hydrotherapy,

Antigravity treadmill, Kaynamatics and wireless cardiac monitoring facilities for cardiac rehabilitation, integrated OT facility, Advanced Robotic systems and have been widely used. IVF and GIFT Units have been specially put to use for women convenience.

Dr. PM Bhujang, President, Association of Hospital said, “Charitable hospitals in the city are having advanced equipments

in various specialities to provide quality healthcare to the patients.

The Trust Hospitals annually spend a significant percent of their annual turnover for the needy patients.

This is because they feel the need to help the weaker section of the society by providing treatment free or at negligible cost. These facilities are provided only to the genuinely deprived people who are unable to pay for minor or major treatments for a healthy living.”

About Association of Hospital: The Association of Hospitals has been formed under the Memorandum dated August 6, 1985 and is registered under the Societies Registration Act, 1860. The Association is also registered under Maharashtra Public Trust Act, 1950 as Public Charitable Trust with the office of Charity Commissioner, Maharashtra State.

Presently there are 52 members of the Association and all of them are Public Charitable Trust Hospitals registered under Maharashtra Public Trust Act, 1950 with the concerned offices of Charity Commissioner, Maharashtra State depending upon the Jurisdiction. The members being not-for-profit charitable hospitals render yeomen service to the public and bear a major share of healthcare service to the people.

Medical Device ASIA | September-October 2015 | 25

After Harley street

Dr.Batra’s homeopathy Clinic launches 2nd clinic in Wembley, London Inauguration by the Mayor of Brent

of Dr Batra’s, Dr Mukesh Batra.

At the forefront of modernizing Homeopathy, guests were able to watch demonstrations of treatments being undertaken, including the use of advanced diagnostic technique, Folliscope.

Dr Mukesh Batra, Founder and Chairman of Dr Batra’s® Group of Companies, said: “We’re delighted to launch our new Dr Batra’s Homeopathic Clinic in the UK. We’re a large brand of professionals’ doctors and so thought we should give the advantage of homeopathy to Indians who live in the UK.”

The UK launch for India’s most trusted homeopathy brand, Dr Batra’s ® took place on Saturday 26th September in its new clinic at 594 High Road, Wembley, HA0 2AF. Guests including the Mayor of Brent, CouncilorLesley Jones, First Secretary, M.P. Singh, High Commission of India, and Registrar of The Trichological Society Barry Stevens along with patients, media and key luminaries were invited to the launch to celebrate.

The launch included a tour of the new clinic with the Founder and Chairman

Mr Barry Stevens MA (Mus) FTTS, Registrar of The Trichological Society said “I greatly admire Dr Mukesh Batra who has saved the health of millions and can almost claim to have re-invented homeopathy for the world. A man with great integrity, ability and foresight, I am privilege to know him.”

Mr MP Singh, First Secretary, High Commission of India said

Medical Devices From Health Line International Health Line International Corp. is a medical device developer, manufacturer and distributor. Health Line produces a comprehensive line of products for vascular access, infusion therapy, and infection control.

• We offer different kinds of Hemodialysis Catheter , and our focus is on patient safety and satisfaction, custom product design, innovative technology, and service for the medical device industry.

• Our Central Venous Catheter with power injectability is indicated for short term(less than 30days)access to the central venous system for intravenous administration .They are available in a variety of sizes and lengths so that clinicians have the options necessary to meet the patient’s needs.

• We offer various types of PICC , the Non-CT PICC is an economical way of achieving the effectiveness of PICC access when power injection is not necessary. Made from polyurethane, the UNI-PICC is a great option for a variety of intravenous therapies.

26 | September-October 2015 | Medical Device ASIA

Otherwise, our CT PICC offers the ease and effectiveness of PICC access with power injectability, creating a synergy of intravenous therapy options for health care practitioners and patients.

• Our CT-Midline Catheter provides dependable 1-4 weeks peripheral access to the venous system for selected intravenous therapies and blood sampling. For maximum flow rate and maximum pressure that can be used during power injection.

• Our various Needleless Connectors to meet the need of clinical application.

“The very fact that Dr Batra’s has over 200 clinics over five countries speaks volume of Dr Batra’s. It is exceptionally heartening to know that a huge successful Indian brand that has emerged in the last 30 years from India is being recognized all over the world and has now come to England.”

The clinic medical expertise will include treatment for: allergies, breathing troubles, eczema, gastric disorders, gynaecological problems, hair problems, high sugar levels, joint pain, overweight issues, psoriasis, sexual problems, thyroid and other health problems for all ages. Dr Batra’s® has provided individualised treatment and care to over 1.3 million patients across the globe with 94% positive outcome.

Founded by Dr Mukesh Batra in 1982 in Mumbai, India, today Dr Batra’s ® Healthcare Group is the leading homeopathic healthcare corporate, having 212 clinics with over370 full-time doctors across 118 cities with its presence in India, Dubai, UK and Bangladesh.

EKF’s unique and simple creamatocrit analyzer highlighted at FIGO Inexpensive and accurate analysis of mother’s milk fat and calories ideal for neonatal ICU care pregnancy tests, Diaspect Tm hemoglobin analyzer and Lactate Scout+ lactate analyzer.

The Creamatocrit™ Plus system helps ensure premature infants receive the calories they need

EKF Diagnostics, the global in vitro diagnostics company, exhibited its range of Maternal and Women’s Health products at the XXI FIGO World Congress at the International Federation of Gynecology and Obstetrics - in Vancouver, Canada, 4-9th October. EKF’s portfolio in this sector has been tailor made to address the specific healthcare needs women face during pregnancy and in their everyday lives.

EKF

presented its

Creamatocrit Plus™ mother’s milk fat and calories analyzer. This novel centrifuge with built-in tube reader is the first and only system dedicated to providing a fast and accurate creamatocrit measure of mother’s milk and estimate of calories. Small and lightweight with whisper quiet 3-minute operation, Creamatocrit Plus™ is particularly useful in neonatal intensive care units (NICU) to ensure that premature infants are receiving the calories that they need to thrive.

Creamatocrit Plus™ guides the separation of foremilk and the high lipid, high caloric hindmilk to accelerate weight gain in extremely low birthweight infants. To achieve this it uses a very simple, inexpensive and accurate technique for estimating the lipid concentration and calorific density in mothers’ milk – a video demonstration of this simple technique is available at www. ekfdiagnostics.com/Creamatocrit_ Plus_1536.aspx Other EKF products being exhibited on Booth #919 at FIGO include its CLIA waived point-of-

Pre-natal lactate testing seminar Notably, EKF also hosted a workshop entitled ‘Lactate in the peripartum period’ where eminent obstetricians preseted on this key measure of fetal well-being.

Professor Gian Carlo Di Renzo, FIGO Honorary Secretary, Perugia University, Italy, provided an overview on ‘Lactate in Obstetrics’.

Professor Wolfgang Henrich and Dr Johanna Stuckenschneider, Obstetrics and Gynecology Hospital Charite-Berlin, Germany, will discuss ‘Dystocia management and the impact of using a lactate point-ofcare device.’

The FIGO World Congress of Gynecology and Obstetrics is a key conference in this field as it uniquely brings together professional societies of obstetricians and gynecologists on a global basis. It is one of the largest international gatherings of obstetricians, gynecologists, midwives, nurses, general practitioners and other specialists working in the field of women’s health. With member societies in 125 countries or territories, over 7,000 delegates from around the world attended the conference.

For more information on EKF Diagnostics and its range of Maternal and Women’s Health products, please visit: www. ekfdiagnostics.com

About EKF Diagnostics - www.ekfdiagnostics.com EKF Diagnostics Holdings plc, which includes the EKF Diagnostics, EKF Molecular, Stanbio Laboratory, Separation Technology Inc., DiaSpect and Selah Genomics brands, specializes in the development, production and worldwide distribution of point-of-care blood analyzers for use in the detection and management of diabetes, anemia, lactate and kidney related diseases. Its new molecular division, EKF Molecular Diagnostics, focuses on technology used within the development of companion diagnostics, specifically within oncology. EKF products are sold in more than 100 countries around the globe, through a network of specialist distributors.

Point-of-care diagnostics: EKF Diagnostics designs and manufactures world-class diagnostic devices, as well as distributing rapid test kits for infectious diseases and pregnancy. The EKF analyzer range is used widely in GP surgeries, pharmacies, blood banks, sports clinics, hospitals and laboratories for glucose, lactate, hemoglobin, hematocrit and HbA1c measurement.

Central laboratory: EKF, through its wholly owned subsidiary, Stanbio Laboratory (Boerne, Texas, USA), manufactures a comprehensive range of clinical chemistry reagents. In addition, EKF Life Sciences (Elkhart, Indiana, USA) manufactures enzymes used in reagent development and also provides contract fermentation facilities.

Molecular Diagnostics: In March 2013 EKF set up a new division to focus on molecular and companion diagnostics following the acquisition of UK-based 360 Genomics. EKF Molecular Diagnostics’ technology, PointMan™, is capable of detecting mutant genes from tiny biopsy and blood samples and has recently entered a partnership with the world renowned cancer research center at Massachusetts General Hospital, USA. EKF Diagnostics’ strengths lie in its multi-national research and manufacturing facilities, teams of experienced analysts and engineers in Germany, Ireland, USA and the UK, and a board led by some of world’s foremost authorities in medical diagnostics.

Medical Device ASIA | September-October 2015 | 27

Catalyst Motion GroupTM Develops Z-Theta System Capability technology.

Z-Theta systems lend themselves well to picker type applications in automated kiosks, data storage libraries, and other repetitive motion tasks requiring both a linear and a rotary move. Loads of up to 100 pounds and speeds in excess of 10 inches/second are possible.

C

atalyst Motion GroupTM, a Haydon Kerk motion system integrator, has created a Z-Theta system capability utilizing in-house branded products. Z-Theta systems offer a compact and effective package to achieve a rotary axis and a linear axis in a single unit, that when operated in coordinated motion can effectively create a helical motion path.

Z-Theta systems also can be used to move to defined linear positions, and then perform independent rotary moves. The Kerk brand ScrewRail® is the centerpiece of this development, with the linear and rotary power being supplied by Haydon and Pittman motor

The Catalyst Motion Group Z-Theta solution is fully customizable and adaptable to a broad range of specific design requirements, providing an innovative and effective solution.

Information on Catalyst Motion Group can be found on its website: www.catalystmotiongroup.com. For help with a specific application, users should call 1-203-725-3852 email info.catalyst@ametek.com or contact: Catalyst Motion Group, 1500 Meriden Road, Waterbury, CT 06705. Phone: 203-725-3852 Fax: 203-756-8724

About Catalyst Motion Group

Catalyst Motion GroupTM is a brand of the AMETEK® Precision Motion Control division. It offers high- precision linear motion systems at all levels of sophistication and integration, providing all necessary mechanical, electrical and software supply and support.

Its expertise includes single-axis and multiple-axis systems using either Haydon, Kerk, Pittman or Dunkermotoren components as well as components custom designed to client specifications. It brings together the resources and support of a global corporation, while providing its customers with the individual attention offered by a small, focused and strategically aligned group from the single point contact.

AMETEK Precision Motion Control is a division of AMETEK, Inc., a leading global manufacturer of electronic instruments and electromechanical devices with annual sales of $4.0 billion.

PRIAMUS acquired by Barnes Group Inc.

P

RIAMUS SYSTEM TECHNOLOGIES AG announced that it has completed its transaction to be acquired by Barnes Group Inc. (NYSE: B), of Bristol, Connecticut, USA.

PRIAMUS services many of the world’s highest quality plastic injection molders in the medical, automotive, consumer goods, electronics, and packaging markets. PRIAMUS has approximately 40 qualified employees and is headquartered in Schaffhausen, Switzerland with direct sales and service offices in the United States and Germany, and distributors across the globe.

Founded in 1857, Barnes Group Inc. (NYSE: B) is an international industrial and aerospace manufacturer and service provider, serving a wide range of end markets and customers. The highly engineered products, differentiated industrial technologies, and innovative solutions delivered by Barnes Group are used in farreaching applications that provide transportation, manufacturing, healthcare products, and technology to the world. Barnes Group has approximately 4,700 skilled and dedicated employees, at more than 60 locations worldwide.

Barnes Group’s Industrial segment includes leading plastics industry technology-based businesses Synventive Molding Solutions, Männer,

28 | September-October 2015 | Medical Device ASIA

and recently acquired Thermoplay, with manufacturing facilities in North America, Europe and Asia as well as sales offices and agents in many countries. With a focus on providing high quality hot runner products and value-added services, Barnes Group delivers complete tool based solutions for all types of injection molding applications.

“The combination of PRIAMUS FILLCONTROL systems with Barnes Group’s hot runner and mold expertise including Synventive’s activeGate products enhances our ability to serve our customers and opens new opportunities for enhanced process control for critical molding applications,” said Christopherus Bader, Managing Director of PRIAMUS. “Becoming part of Barnes Group will allow both companies to realize faster growth together than each could achieve on its own.”

PRIAMUS will operate as a business within Barnes Group’s Industrial segment.

PRIAMUS SYSTEM TECHNOLOGIES AG Rheinweg 4, CH-8200 Schaffhausen / Switzerland www.priamus.com Contact: Christopherus Bader, +41 (0)52 632 2600

Is the Russia crisis also a crisis for medical technology?

Interview with Jennifer Goldenstede, head of department Foreign Trade and Export Promotion at SPECTARIS e.V., Association for Medical Technology The Ukrainian political turmoil has been keeping the world in suspense since 2013. It has also caused growing tensions between Russia on the one hand and the U.S. and EU on the other hand. Both sides try to pressure each other with sanctions against individuals, international financial transactions and whole industry branches.

In the interview with MEDICAtradefair.com, Jennifer Goldenstede talks about exports of medical technology to Russia and explains the trade sanctions’ impact on the industry.

Miss Goldenstede, how important are medical technology imports from the U.S. and the EU for Russia?

Jennifer Goldenstede: In recent years, they had a high significance, but this has changed now. One example is the German exports to Russia. From 2010-2012 there has been a considerable increase of more than 30 percent each year, reaching almost 70 percent in 2012. In 2013 and 2014 those figures decreased with a decline of around 25 to 30 percent each year. In the first half of 2014 the export volume was still at 292 million Euros, in the first half of 2015 the volume was at 226 million Euros. This means a decline of 23 percent.

There currently are economic as well as travel sanctions between the U.S. and the EU on one side and Russia on the other side. What influence do these have on the manufacturers of medical technology?

Goldenstede: The economic sanctions are not the foremost problem for the industry – this would be the import substitutions. The Russian government has decided that those manufacturers of medical technology should be preferred in public government tenders, which really provide added value within the Eurasian Economic Union. There are lists which indicate for which goods and expendable materials the Russian import quota should be lowered more and more. Of course Russian companies are the ones which profit most from this. Foreign companies first have to create added value locally to be able to participate in those tenders.

trade relations in difficult times; Španthermedia.net/ doomu How can a trade association like SPECTARIS again promote cooperation between these countries?

Goldenstede: We are strongly committed to ensuring that foreign trade fairs such as the ZDRAVOOKHRANENIYE in Moscow can continue to take place. There already were some cancellations out of political reasons in the foreign trade fair program. However, these have not yet affected the medical technology industry.

Other instruments that we can use are for example the market development program of the Federal Ministry of Economics, which includes visits of delegations to the country. We have proposed, inter alia, Russia as a destination country. However, it is still unclear whether this will be implemented.

Lastly, the information transfer to the member companies is very important.

They need to know what is happening in Russia, so they can be prepared and make informed decisions about their business there.

Thus, these sanctions are only consequently an obstacle for companies that want to export to Russia: If a national procurement is not possible, the Russian authorities first check if they can purchase the products from countries that do not sanction Russia.

Building bridges: Industry associations can work to maintain and to promote international

Medical Device ASIA | September-October 2015 | 29

India’s First Nicotine Patch, 2baconil™ Launched by Rusan Healthcare

270,000,000 Indians risk cancer everyday of their lives

R

usan Healthcare – a marketing arm of the parent company Rusan Pharma Ltd has recently launched India’s first fully indigenous Nicotine patch 2baconil™, which is a global pharmaceutical company with interests in R&D, Manufacturing and Marketing of formulations, APIs and their intermediates. With 270 million Indians addicted to tobacco in one form or the other, with the launch of 2baconil™ patches a new form of Nicotine Replacement Therapy (NRT) is now available in India to the doctors and patients seeking treatment for tobacco de-addiction.

According to a study done by Global Adults Tobacco Survey (GATS), ~60% of Indians smokers consume tobacco within the first 60 minutes of waking up. Smokers today have also reached an age group of 13-15 years according to the WHO, with 8 million global deaths predicted every year by 2030 at current growth rates.

Speaking at the launch, Dr. Navin Saxena, Chairman, Rusan Pharma Limited said, “With 6 trillion cigarettes being smoked a year in India, our vision has been to bring products into the market which will be not just quality driven but also bring convenience to users, through newer delivery systems transdermal patches, which ensures higher patient compliance and ease of use. If we are in knowledge of the fact that there are millions of Indians going to die, especially the youth, then our efforts need to be intensified and focused on saving their lives.”

The average Indian smoker consumes 8.2 cigarettes a day. By conservative estimates, that’s close to an hour of lifetime that a smoker loses every 30 | September-October 2015 | Medical Device ASIA

day. When coupled with figures for man hours, and how this impacts the economy, India seems headed for a disaster, and surprisingly tobacco seems the cause.

Rusan Pharma Ltd. – One stop solution for De-addiction & Pain Management products in India & Globally.

Rusan Pharma Ltd. is a fully integrated global pharmaceutical company with interests in Research and Development, Manufacturing and Marketing of formulations, APIs and their intermediates.

Rusan Pharma Ltd. as an organization can be counted among the very few companies in India and globally which caters to end to end solution in De-addiction & Pain management. Globally, Rusan is the second largest manufacturer and marketer of oral substitution therapy used for treatment of injecting drug users (IDUs).

Rusan is one of the reputed and largest suppliers of life saving drugs (Deaddiction, pain management and anti-TB drugs) to various organizations / ministries like NACO, UNODC, UNOPS, Global Fund, Ministry of Health, Ministry of Justice of countries like India, Europe, UK, Russia, CIS, South Africa, Mauritius, Nepal, Myanmar. Since 1994, Rusan has been in the forefront of making Opioid Substitution Treatment (OST) an acceptable form of treatment in India. Rusan has been working closely with various NGOs, doctors, hospitals, clinics, reputed government institutions such as AIIMS, NIMHANS, funding agencies such as Global fund, DFID and now NACO for scaling up the OST in India

ResMed launches ‘AirSenseTM 10 Autoset’ to Clinical Computer Systems, Inc. receives the 2014 KLAS® Category Leader Award treat Obstructive Sleep Apnea • •

Designed to provide unprecedented comfort and clinical efficiency at every stage of treatment.

Offers better therapy, greater comfort and ease of use to patients with sleep disorders

ResMed India, a medical device company that specializes in treating sleep disordered breathing and other chronic diseases has launched its latest generation auto adjusting pressure device AirSenseTM 10Autoset which is designed to offer better therapy, greater comfort and ease of use to the patients.

Packed with cutting-edge features and technology, AirSenseTM 10 Autoset is designed to provide unprecedented comfort and clinical efficiency. Each device comes with integrated heated humidifier, HumidAir™ and enhanced Climate Control through ClimateLineAirTM which helps to deliver the optimal temperature and humidity. It also comes with enhanced AutosetTM algorithm thus delivering the ultimate experience in sleep.

This advanced APAP device that comes with additional features like: • AutoRampTM with sleep onset detection is designed to make therapy as comfortable as possible.

• Cheyne Stokes Respiration Detection provides valuable information to the physicians on the continued health of their patient.

• AutosetTM Response feature offers all the benefits of AutoSet therapy with added options of gentler pressure increases for a more comfortable night’s sleep.

• Ambient Light Sensor adjusts the brightness of the screen based on the amount of light in the room.

• QuickNavTM feature gives a user-friendly interface.

• Easy-Breathe Motor makes the device noiseless and allows the patient and the bed-partner a quiet sleep every night.

Speaking on the launch of the product, Mr. Aparajito Mukherjee, Managing Director, ResMed India Pvt. Ltd. said, “The launch the AirSenseTM 10 Autoset reflects our commitment to provide innovative solutions to improve the quality of life of patients. It is based on close partnership and extensive research with clinicians, patients and caregivers and our experience in sleep disorders.”

Sleep disorders is a growing concern and represents a significant number in India. Recent estimates of OSA prevalence suggest that 13 per cent of men and six per cent of women in India have OSA About ResMed

ResMed is a global leader in the development, manufacturing and marketing of medical products for the treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. With more than 4,000 employees and a presence in over 100 countries, the company has been pioneering new and innovative devices and treatments for more than 25 years.

ResMed is committed to advancing innovative technology and solutions that will improve the quality of life for millions of patients worldwide, reduce the impact of chronic disease and save healthcare costs.

Clinical Computer Systems, Inc. (CCSI) is excited to announce that its OBIX® Perinatal Data System has been named as the category leader for labor and delivery in the January, 2015 KLAS® Report, “2014 Best in KLAS Awards: Software & Services”. This is the tenth consecutive report (a combination of Best in KLAS and Labor and Delivery Specialty Reports) in which the OBIX system has been ranked #1 in labor and delivery.* The OBIX system is a comprehensive, computerized system for central, bedside, and remote electronic fetal monitoring. It includes archiving, pointof-care charting, single-click management reports, interface capabilities, and multi-facility support. E-Tools help clinicians to promote patient safety in electronic fetal monitoring and improve practices. The system is developed using the latest technology and able to be deployed in different environments to utilize the hospital’s current strategy and infrastructure.

“We are honored to receive this recognition from our customers for the 10th consecutive time. This recognition is a testament to the dedication and talent of our employees, all of whom take ownership of delivering excellent service and support.” said Kim Sell, President of CCSI. “Customer satisfaction is a core value that we work on continuously to earn and maintain the trust of our customers.” Pat Dwyer, Director of Business Development, added “CCSI is committed to our customers and providing solutions that fit within their strategy. Our collaborations with leading companies and business relationships have contributed towards customer satisfaction and improved workflow efficiencies.”

About Clinical Computer Systems, Inc. CCSI is an employee-owned, high technology company located in Elgin, Illinois. The company’s business is dedicated to the development, marketing, and support of the OBIX Perinatal Data System. For over 20 years, CCSI has been a leader in perinatal data systems with innovative, customer-driven, computer-based solutions, and support services. The company’s total-system approach includes expert service and support specialists. The system is designed for interfacing with hospital-wide solutions and electronic medical record systems. For more information, go to www.obix.com or call +1-888-871-0963.

About KLAS KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and to be counted. Working with thousands of healthcare professionals and clinicians, KLAS gathers data on software, services, medical equipment, and infrastructure systems to deliver timely reports, trends, and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. Follow KLAS on Twitter at www.twitter.com/ KLASresearch. *The research findings were published in the January 2015 KLAS® report “2014 Best in KLAS Awards: Software & Service”; January 2014 KLAS report “2013 Best in KLAS Awards: Software & Service”; December 2012 KLAS report “Best in KLAS Awards: Software and Professional Services”; May 2012 KLAS® report “Labor and Delivery 2012: Pursuing Interoperable Functionality”; December 2011 KLAS report, “2011 Best in KLAS Awards: Software & Services”; December 2010 KLAS report, “2010 Top 20 Best in KLAS Awards: Software & Professional Services”; September 2010 KLAS report, “Labor & Delivery 2010: Who’s Evolving, Supporting, and Integrating?”; December 2009 KLAS report, “2009 Top 20 Best in KLAS Awards: Software & Professional Services”; December 2008 KLAS report, “2008 Top 20 Best in KLAS Awards: Software & Professional Services”; March 2008 KLAS report, “Labor & Delivery”.

Medical Device ASIA | September-October 2015 | 31

MEDICAL FAIR THAILAND continues to attract international interest 600 exhibitors from 42 countries, 15 national

pavilions and country groups 7,226 visitors from 59 countries, representing a 13% increase from the previous edition

T

he global footprint of MEDICAL FAIR THAILAND 2015 was firmly fortified as the 7th edition of Southeast Asia’s most established medical and health care event that came to a close on 12 September with 7,226 trade visitors from 59 countries. The 3-day exhibition which focused on hospital, diagnostic, pharmaceutical, medical and rehabilitation equipment and supplies, welcomed 600 exhibitors from 42 countries including 15 national pavilions and country groups from Austria, Belgium, China, France, Germany, Japan, Malaysia, Singapore, South Korea, Taiwan, Thailand, UK and for the first time the USA, Turkey and Italy. The internationality of the exhibition was further reflected in the number of visitors, an increase of 13% compared to the last edition in 2013.

32 | September-October 2015 | Medical Device ASIA

34% of the overall visitors came from overseas, mainly from ASEAN countries such as Singapore, Malaysia, Myanmar, Philippines and Vietnam, as well as other Asian countries including China, India, Japan and Taiwan.

On the domestic front, Thai visitors recorded a 17% increase, which included visiting delegations from more than 60 hospitals from across Bangkok and surrounding provinces.

According to Mr Watcharin Boonshuwong, Chief of Patient Care Services, Praram 9 Hospital, Bangkok, who was visiting for the first time and in search of medical devices and instrumentation for use in the emergency ICU wards, “the diverse range of products from

various countries is very impressive and I would certainly encourage my colleagues from the hospital to visit this exhibition.”

Thailand’s Minister of Industry, Dr Atchaka Sibunruang, who officiated at the opening of the exhibition, underscored the importance of MEDICAL FAIR THAILAND which reflected the fast paced growth of the medical and healthcare industry.

In her opening address, Dr Atchaka said the exhibition is a significant event for the modernization and development of the medical and healthcare industry for Thailand and the Southeast Asian region and “an important step for Thailand to prepare local personnel and professionals in the field to be ready

for the integration of the region under the AEC (ASEAN Economic Community).”

For many exhibiting companies, particularly small and medium sized firms, the resounding sentiment was the relevance of MEDICAL FAIR THAILAND as a stepping stone to penetrate the ASEAN market and to introduce their latest technologies.

Mr Michael Richardson, Senior Vice President of the US firm Perry Baromedical, said: “The Southeast Asian market is becoming more significant, which is why we have come to the exhibition to increase our network and meet with existing and new distributors in the region.

The number of visitors, sales leads and new contacts from Vietnam, Laos, Thailand, Indonesia, Malaysia, Philippines and Singapore that we have been able to generate has been excellent.”

Malaysian exhibitor LKL Advance Metaltech Sdn Bhd added that “There have been some very interesting leads the event has generated – of which we seldom come across in other medical shows. Thailand may prove to be the centralized hub for the ASEAN & Pacific region”, said Export Manager, Mr Brandt Lee. For long time exhibitor and renowned medical vehicle solution provider, Dlouhy, who has been exhibiting at MEDICAL FAIR THAILAND since 2005, Mr Wolfgang Binder, Director of Sales, said: “The

size of the exhibition has grown exponentially allowing us to present our latest developments and improved products to existing as well as new customers from Thailand and across the Southeast Asian region. We had a very good experience at the 7th edition and will be back again in 2017!”

The ability to link up exhibitors with relevant distributors, suppliers and agents and vice versa and catering to the different solutions and visitor needs across the various specializations and broad healthcare channels at MEDICAL FAIR THAILAND, proved to be a key element that contributed to the exhibition as a significant sourcing platform.

The business matching programme that was offered as a value-add service, saw a healthy take up rate of 4,500 meeting requests made. Ms Sarah Liebermann, an exhibitor from DEWIMED Medizintechnik GmbH found the platform user friendly and a “useful tool where I’ve found potential leads via the scheduled meetings.”

Alongside a show floor that had the medical and health care community buzzing, the unprecedented number of concurrently held seminars, forums, conferences and technical presentations such as the CIO Forum organized by the Thai Medical Informatics Association, the seminar on Electro-magnetic Waves organized by the Thai Association

for Medical Instrumentation and the seminar on Biomedical Engineering Technology organized by The Thailand Center of Excellence for Life Sciences, also received an overwhelming response.

industry will be the 11th edition of MEDICAL FAIR ASIA, to be held in Singapore from 31 August to 2 September 2016. Participation details are now available at www.medicalfair-asia.com

The 2nd Advanced Rehab Technology Conference (ARTeC) jointly organized by Messe Düsseldorf Asia, Royal College of Physiatrists of Thailand and Thai Rehabilitation Medicine Association, featured a seminar on interventional spine care led by Dr David J Kennedy and Dr Matthew Smuck from Stanford University Medical Center, while a parallel conference track that included hands-on workshops on musculoskeletal sonography on the wrist, elbow and hip were led by Dr Chueh-Hung Wu, as well as Dr YiChian Wang both from Department of Physical Medicine and Rehabilitation of the National Hospital Taipei, Taiwan.

About Messe Düsseldorf Asia (MDA)

Commenting on the success of the ARTeC conference, Dr Waree ChiraAdisai, President, The Thai Rehabilitation Medicine Association: “This time we have gathered more rehab specialist doctors to the conference, and we hope to keep this growing stronger over the years so it becomes a regular academic conference in line with MEDICAL FAIR THAILAND.” The next edition of MEDICAL FAIR THAILAND will be held in 2017. Up next for the medical and healthcare

MDA is a subsidiary of Messe Düsseldorf in Germany, one of the world’s leading trade fair organizers, responsible for organizing more than 20 global No. 1 exhibitions in industries including plastics, printing and packaging, and medical and health care - specifically K, drupa, interpack, MEDICA, COMPAMED and A+A held in Düsseldorf, Germany.

Since 1995, MDA’s portfolio of trade fairs in Southeast Asia includes: for the plastics and rubber sectors in Thailand (T-PLAS), Vietnam (PLASTICS & RUBBER VIETNAM) and Indonesia (INDOPLAS), the printing and packaging sectors in Thailand (PACK PRINT INTERNATIONAL) and Indonesia (INDOPACK and INDOPRINT), the wire, cable, tube and pipe sectors in Thailand (wire Southeast ASIA and Tube Southeast ASIA), the medical and health care industries in Thailand and Singapore (MEDICAL FAIR THAILAND, MEDICAL FAIR ASIA, MEDICAL MANUFACTURING ASIA) the Workplace Safety & Health sectors in Singapore(OS+H ASIA) and the metal and steel trade industries in Indonesia (indometal).

Medical Device Asia | September-October 2015 | 33

MEDICAL FAIR THAILAND

Show Glimpses

34 | September-October 2015 | Medical Device ASIA

Transasia buys a UK based molecular technology company for Rs. 250 crores

M

umbai headquartered Transasia Bio- Medicals Ltd., India’s largest in-vitro diagnostic company announced its acquisition of Lumora Ltd., a Cambridge, UK based patented molecular technology company for about Rs. 250 crores.

This makes Transasia one of the select few global companies with its own patented technology for the Rs. 35,000 crore global market for molecular testing.

Transasia Bio-Medicals Ltd., India’s largest in-vitro diagnostic company has been providing reliable, accurate and affordable diagnostic solutions for over thirty five years now.

Through its overseas subsidiaries in eight continents, Transasia Group

has been meeting the needs of doctors and patients worldwide in over 100 countries. In India, Transasia services over 20,000 laboratories in over 200 towns and cities performing blood tests for over 20 crore people. The acquisition will see ERBA-Transasia Group add advanced molecular diagnostics testing to its comprehensive suite of clinical testing products & make them available worldwide for testing of diseases such as HIV, respiratory diseases, dengue, malaria, etc.

Global market for molecular tests is estimated to be about Rs. 35,000 crores per year.

Alongwith the specific diagnostic technologies, the Transasia Group will have the opportunity to further commercialise Lumora’s patented

technologies such as BART, RapidMag, and other sample preparation technologies. In addition, Lumora, has a number of ongoing commercial partnerships which will continue following the acquisition.

Dr. Laurence Tisi, CEO of Lumora, said: “The ERBA-Transasia Group is an excellent home for Lumora’s technology. The company has a strong global presence and is well established in a number of key market segments. With the acquisition of Lumora, and its novel technology, the Group is now well placed to expand the utility of the technologies globally.”

Mr. Suresh Vazirani, Chairman and Managing Director of the ERBA-

Transasia Group, said: “The acquisition of Lumora enhances and completes our existing portfolio of instruments & test kits, to make ERBA- Transasia a global IVD leader.

Lumora has a strong portfolio of molecular technologies which will help us develop molecular testing for emerging country specific diseases such as HIV, TB, malaria, dengue, etc.”

For Advertising in Medical Device Asia Please contact: info@medicaldeviceasia.in www.medicaldeviceasia.in

Medical Device ASIA | September-October 2015 | 35

Global Hospitals Mumbai, Brief History

G

lobal Hospitals Mumbai is one of the country’s fastest growing chains of Multi Super Specialty Tertiary Care Hospitals offering healthcare services of international standard.

Global Hospital Mumbai was launched in the month of October 2012. The hospital is built as per NABH standards with 400 in-patient beds including specialized facilities for critical care needs, covering all super specialties and diagnostics.

Global Hospitals is a pioneer in Multi-Organ Transplants. The hospital has specialized teams for kidney and liver transplantation. The hospital is spread across an area of 267000 sqft, located at Parel with convenient proximity to airport, railway and bus station.

Mission and Vision The Mission of Global Hospitals

Group is to achieve the dream of a healthy world through continuous innovation, dedication to quality, provision of compassionate and affordable medical services. To carry out this mission Global Hospitals strongly believes in • Deploying state-of-the art facilities and equipment • Attracting the most talented medical, scientific and support staff • Providing affordable health care of unsurpassed quality • Exceeding service expectations • Adhering to professional and scientific integrity • Embracing change and encouraging innovation Vision Global Hospital’s vision is to be a world-class medical services provider turning distant possibilities into today's realities.

36 | September-October 2015 | Medical Device ASIA

Services / Facilities offered: Patient Care: Patient care is at the core of everything that we do in the hospital. The hospital has various centers of excellence and institutes to meet healthcare needs of patients.

Global Institute Of: • Liver diseases, HPB Surgery and Transplantation • Renal Sciences and Transplant • Gastroenterology and GI Endoscopy • Cardiac Sciences and Transplant • Neuro Sciences Centre of Excellence For: • Vascular Surgery • Minimal Access, Bariatric and General Surgery • Bone Marrow Transplant Department Of: • Internal Medicine • Orthopedics and Spine

• Emergency Medicine and Trauma Care • Endocrinology • Pulmonology • Radiology • ENT • Gynecology • Infectious Diseases • Opthalmology, are some of the specialties wherein we provide treatment facilities to patients. To our in-patients we provide beds ranging from general ward to super deluxe (suites) as per their requirement.

Global Hospitals Mumbai is the only hospital with specialty specific ICU beds – Liver, Renal, Cardiac, World class OTs and ICUs (single shell, having no joints to reduce infection) Emergency Services: Global Hospitals provides round-the-clock Emergency Services to meet contingent medical situations. The primary mission is to provide acute care to the patients and stabilize

highly specialized team of doctors for each of it’s specialties and will continue to do so in the future • Global Hospital team is in constant touch with independent physicians to meet the advanced healthcare needs of their patients • Global Hospital specialists participate in healthcare conferences to share their practice experiences & learn from industry best practices • To reach out to patients located in far flung areas tele-medicine is being explored • The hospital has made a mark in liver and kidney transplants and plans to initiate lungs, heart, intestine and pancreas transplants.

• The hospital recently started Bone Marrow Transplant Unit • The team is working relentlessly to be the choice of hospital for tertiary and quaternary care in the region Accreditations cases of trauma. Emergency services including ambulance services and specialized treatment areas.

Staffed with trauma physicians, emergency room physicians, surgical residents, and nurses, Global Hospitals is prepared to respond to all contingencies at all times.

International Services: We have a dedicated team that services International patients during their stay at our Hospital. We cater to the medical needs of International patients on the basis of their nationalities and cultural preferences.

Corporate Services: Close to 100 Corporate and Third Party Administrators (TPAs) in the island city are empanelled with us. As a part of these tie-ups we provide IPD and OPD services, executive health check-up packages. We also conduct health awareness activities like camps and talks for our corporate clients.

Facility Management & Support Services • Highly specialized support staff for 24x7 care

• Only hospital with specialty specific ICU beds – Transplant, Liver, Renal, Cardiac etc.

• World class OTs and ICUs (single shell, joint free) • Post transplant recovery unit • State-of-the-art Bone marrow transplant unit • All critical areas are equipped with hepa-filters • All patient areas have antimicrobial flooring Equipments To provide best possible patient care Global Hospitals invest in best of the technology and will continue to do so in future. Some of the world class equipments used at the hospital are listed below: • High Definition Dual Energy 500 slice 4 D Dynamic CT Scanner from GE Healthcare • IGS 530 Cath Lab • ThuLEP dual laser machine for enlarged prostate • 3 Tesla MRI • Digital Radiography (X-ray) • Lithoclast for stones etc.

• Close to 70 Liver Transplants • Close to 1000 joint replacements till date • 300 plus Cardiac surgeries, 1500 plus Angiographies, & over 250 Angioplasties and 500 plus other Cath procedures • World Class Gastroenterology & Endoscopy Institute - Biggest in India • Over 10000 Endoscopic Procedures till date • Close to 1000 MAS & Gen. surgeries till date • Close to 1000 Urological surgeries till date.

Global Hospitals Mumbai, Centers of Excellence are equipped with stateof-the-art technologies to provide best in class treatment to patients.

Some of the remarkable cases that Global Hospital have handled in the recent past, include - West India’s first dual transplant (liver and kidney), West India’s first dual lobe liver transplant, West India’s first Auxiliary Liver Transplant, ABO incompatible renal transplant, Minimally invasive spine surgeries, laparoscopic (key hole) general surgeries & laparoscopic nephrectomies etc.

Medical Milestones/Key Achievements

Expansion Plans

• Close to 125 kidney transplants

• The hospital has put together

Accreditation is important not only from the point of view of endorsement from an external agency but also because it helps the hospital in improvising it’s own processes in providing quality care.

Global Hospitals Lab has been awarded the prestigious NABL accreditation by the National Accreditation Board for Testing and Calibration Laboratories.

Total Quality Management We strive to provide world class quaternary healthcare to people in India and abroad by fusing the benefits of modern technology with the clinical acumen of the leading specialists in their respective fields.

To provide compassionate and affordable medical services, we have developed a quality assurance system based on Total Quality Management Concept which has helped us in • Streamlining our clinical pathways and protocols as per international standards, ensuring our internal Supply Chain remains robust to include last minute specific requirements • Seek feedback from patients • Strategic planning to enhance the patient experience

Medical Device ASIA | September-October 2015 | 37

Our organization-wide management philosophy aims at embedding awareness of quality among all staff and involving every process of the organization in a cycle of continuous improvement with the aim of satisfying the customers’ needs and expectations.

Global hepatitis B virus therapeutics market value will increase from almost £3 billion in 2014 to $3.5 billion by 2021

About the Group:

The value of the global Hepatitis B Virus (HBV) therapeutics market will increase modestly over the next 6 years, from almost $3 billion in 2014 to $3.5 billion by 2021, representing a Compound Annual Growth Rate (CAGR) of 2.3%, says business intelligence provider GBI Research.““The company’s latest report* states that this rise will occur across the eight major markets of the US, Canada, the UK, France, Germany, Italy, Spain and Japan, and will be primarily driven by increasing immigration from medium and high-prevalence countries.

Global Hospitals Group was started as a 50 bedded Hospital in Hyderabad in 1999 by Dr. K. Ravindranath, Chairman & Managing Director, Global Hospitals Group.

Over the last 15 years the Global Hospitals Group has transformed into one of India’s fastest growing chains of 2000 bedded multi super specialty tertiary care hospitals offering a comprehensive healthcare network providing quality care across Hyderabad, Chennai, Bangalore and Mumbai.

The group is a pioneer in multi-organ transplants including kidneys, liver, heart and lungs.

The Group offers most advanced clinical services across several disciplines and specialties accessible to all the segments of the society with utmost care and compassion.

Market growth will be driven primarily by increasing immigration from medium and high-prevalence countries, says report“Global Hepatitis B Therapeutics Market Value to Grow Slowly to $3.5 Billion by 2021, says GBI Research NEW YORK (GBI Research).

Priyatham Salimadugu, Analyst for GBI Research, says: “The US, which has one of the largest shares of the HBV treatment market, sees considerable migration from high-prevalence countries, such as the Philippines, China, and Vietnam.

While immigration will enlarge the patient pool, HBV treatment market expansion will be restricted by prophylactic vaccination in the US and much of Europe. However, the analyst adds that the increasing use of the premium therapies tenofovir and entecavir will help to drive the market during the forecast period. Despite this, the global latestage pipeline is weak due to the lack of first-in-class and innovative products in late-stage clinical development.

Salimadugu continues: “The products in late-stage development are either mostly generic, biosimilar or an alternative salt formulation, such as GS-7340, which is a different salt formulation of Viread. As a result, apart from GS-7340, which will capture Viread’s prescription share, the pipeline products are not going to impact the market by 2021.

Furthermore, overall low diagnosis and treatment rates due to the asymptomatic nature of the condition and a lack of awareness, coupled with current drugs serving the market adequately, will hinder further growth. Leading brands treating the condition are also facing competition from generic drugs as major patents approach expiry.

According to GBI Research, the patents of HBV therapeutics expected to expire during the forecast period include Roche’s Pegasys, Gilead’s Viread and Novartis’ Sebivo. Hepatitis B Therapeutics in Major Developed Markets to 2021 – Increasing Number of Migrants from High-Prevalence Regions to Drive Market Growth

Mr. Manpreet Singh Sohal Mr. Manpreet Singh Sohal is a law graduate with hospital management course from Singapore Management University with over 13 years of experience in the field of healthcare. Noteworthy are Fortis Hiranandani Hospital, Navi Mumbai ,Fortis Jessaram Hospital, New Delhi and as CEO of Fortis SL Raheja Hospital, Mumbai. He has been head of Legal operations of the gigantic Fortis group of Hospitals. He has also worked as CEO of Punjab Institute of Medical Sciences, Jalandhar. He is an industry expert having a career spanning over 24 years, with ability to turn around sick hospitals into profitable ventures with strong Entrepreneurial, operations, processes, leadership and people management skills.

Mr. Sohal is presently working as CEO for Global Hospitals, Mumbai & Hyderabad.

38 | September-October 2015 | Medical Device ASIA

HAYDON KERK MOTION SOLUTIONS INTRODUCES

WGS Compact Integrated Screw/Slide System application specific customization.

Linear guides without the drive screw also are available.

For more information about Haydon Kerk products, contact: Haydon Kerk Motion Solutions, 1500 Meriden Road, Waterbury, CT 06705.

Telephone: (toll free) 800-243-2715 and (international) +1- 203-7567441. Fax: 203-756-8724. E-mail: info.haydonkerk@ametek.com.

Web site: www.haydonkerk.com ABOUT HAYDON KERK MOTION SOLUTIONS, INC. Haydon Kerk Motion Solutions is a business unit of AMETEK, Inc., a leading global manufacturer of electronic instruments and electromechanical devices with 2014 annual sales of $4.0 billion.

H

aydon Kerk Motion Solutions has added the WGS Wide Guide Screw to its linear slide product line. Made from the same quality components used in the RGS® Linear Rail Series, the WGS Linear Slide utilizes a screw-driven carriage that offers reliable, continuous linear speed, while maintaining accurate positioning. Length and speed of the WGS are not limited by critical screw speed, allowing high RPM, linear speed and long stroke lengths.

The WGS slide has a unique, compact profile that provides improved torsional stiffness and stability versus Haydon Kerk’s existing RGS and RGW slide

products. An integral mounting base can provide support over the entire length, which can extend up to 8 feet (2.4 meters). Longer lengths are available on a special order basis.

Standard leads include .100-in, .200-in, .500-in and 1.00-in (2.54, 5.08, 12.7 and 25.4 mm) travel per revolution. Information on other available imperial and metric leads is available at www.haydonkerk.com.

There are short leads for nonbackdriving vertical applications, eliminating the need for brakes, as well as longer leads capable of speeds of more than 60 inches per second (1.5 meters per second),

which rival belts and cables while offering superior positioning accuracy, repeatability, axial stiffness and lower maintenance costs. The WGS utilizes sliding plane bearings on a low-profile aluminum guide rail that keeps the motion smooth throughout the travel distance. The lead-screw is precision made of high-quality stainless steel rolled onsite at a Haydon Kerk manufacturing facility.

All moving surfaces include Kerkite® high-performance polymers running on a Kerkote® TFE coating. The slides come with wear-compensating, anti-backlash driven carriages.

Additional driven or passive carriages can be added, along with

Haydon Kerk Motion Solutions is the joining of two world-class brands in the field of linear motion: Haydon Switch and Instrument, Inc. and Kerk Motion Products, Inc. Together as Haydon Kerk Motion Solutions, they offer a wide range of high-performance and precision linear motion products.

Recognized as a leading manufacturer of stepper motor-based linear actuators, rotary motors, lead screw assemblies, and linear rail and guide systems used in niche market applications, Haydon Kerk Motion Solutions has developed industryrenowned brands built upon its technical innovation, versatility, customization, product durability, and dedicated customer service.

Medical Device ASIA | September-October 2015 | 39

Living-donor liver transplant

by A.S. Soin

What is Living-donor liver transplant?

Living-donor liver transplantation offers an extremely successful alternative to deceased-donor organ transplantation. In living-donor liver transplant, surgeons remove a portion of a living donor's liver.

Another surgical team then removes the recipient's entire diseased liver and replaces it with a portion of the living donor's healthy liver. The donor's liver and the portion of the donor's liver given to the recipient grow back to their full size within a few weeks.

What is donor eligibility and information?

Living donors can include: Family members – first and second degree Spouses The following are not allowed to donate: Distant relatives Friends Neighbors Co-workers Staff Living-Donor Liver Surgery Eligibility Potential living liver donors should: Be between the ages of 18 and 55 Not be overweight Have a matching blood group (the same or blood group O; Rh + or – status is not important) Be in good general health and have no history of: Liver disease, including cirrhosis and hepatitis B or C Heart disease Uncontrolled diabetes HIV Cancers which could have or

other diseases that could either spread to the liver or complicate the surgery What are the benefits to the recipient of having a living liver donor versus a cadaver donor?

There are several advantages of living donor transplants. First, the success rate of live donor transplants is a little higher than deceased donor transplants. Second, the rejection rates of liver grafts are lower than those from deceased donors. Third, patients needing urgent transplant can get their family member to donate within 1-2 days, whereas getting deceased donor liver grafts that quickly is usually never possible.

By the same logic, patients can have an early, planned living donor transplant when they are in the best physical and psychological condition to receive it. However, in case of a deceased donor, it is always an emergency transplant, and involves waiting for several months with patients often deteriorating during the waiting period.

gists, transplant coordinators and meet with people who have previously donated parts of their livers to allay their anxiety.

What is the recovery process for the donor?

Myth: The donor is at the risk of morbidity, temporary illnesses, surgical complications, or long term nonfatal disabilities, which is related to Living Donor Hepatectomy.

The donor is recovering from a major abdominal surgery. The first few days will require pain medications. The donor will be given as much pain medication as they need to make them feel comfortable.

Donors are extubated in the operating room. They typically receive no blood products and can go home about five to seven days after surgery.

Fact: The real statistics for the same are anywhere between 2-3% of all the cases in highly experienced centres.

Even when they happen, these morbidities are almost always successful treated with medicines, radiologic interventions, or minor surgery and do not result in excessive re-hospitalisation stays or any debility.

How long do we need to stay in the area following surgery?

Myth: The donor will lose the donated part of the liver which will sooner or later result in unhealthy liver.

The recipient will need to stay in the area for 2-3 weeks following hospital discharge for weekly blood work and visits to the transplant clinic. The donor will need to stay in the area for approximately 1 week following discharge.

How long are donors followed?

What are the risks to the donor from the surgery?

With increasing expertise and in high volume centers, the risks of living donor surgery are minimal. Like in any surgery, they can rarely have wound infections, bleeding and the need for blood transfusions in the operating room, excessive abdominal drainage, bile leakage and minor chest infections.

However, most donors are discharged within a week, and their postoperative problems are sorted out within 2-3 weeks after which they do not need any medical attention or medicines.

We know that donors have lots of questions, so they are counseled by surgeons, hepatologists, psycholo-

40 | September-October 2015 | Medical Device ASIA

Donor follow-ups are at 1, 3 and 12 months.

Myths and Facts Myth: The donor is at risk of a lengthy and potentially dangerous surgical procedure without accruing any health benefit.

Fact: The mortality risk for Living Donor Hepatectomy (liver segment removal) is extremely small in large volume transplant centers like the Medanta Liver Institute where more than 2000 such operations have been performed successfully by some of the most experienced experts in the field.

Fact: The transplanted liver in a recipient and the remnant liver in a donor, grow back to their normal size Liver regeneration is more than half completed by 2 weeks and takes 68 weeks to get back to the size of a normal healthy liver.

Myth: It may not be safe to be a livingdonor for liver transplant.

Fact: In any live donor liver transplant, ensuring safety of the donor is of paramount importance for the team.

In fact, a detailed pre-operative evaluation is done for the donor for two reasons: first to assess if the operation will be safe for them, and second, to assess the suitability of their liver for the recipient. Hence donating just a part of the liver will make not make any difference to the donor’s health in the medium and long-term (after the initial 2-3 weeks), but would definitely give a new lease of life to the recipient.

A REVOLUTIONARY HEALTHCARE EXPERIENCE AWAITS US

MEDBOX™ – Simplifying Healthcare, Simplifying life who need it”, reports Mr. Prateek Kothari – Asst. Product Head for the same.

Till now MEDBOX™ serves to all the major verticals of healthcare industry viz. doctors, patients, pharmacy stores, and diagnostic centers and envision to cover hospitals, emergency services, medical insurance and many more.

“We are quite positive about this project and also aim to bring this service at a platform where it can be reached by maximum number of patients in need. We hope to make the entire healthcare and medical treatment procedure a very smooth and easy one for all”, says Mr. Suyash K – Cofounder and CEO, b2c digital pvt. ltd.

M

EDBOX™ is a collaborative platform healthcare solution providing end-toend services and envision India where consumers can find easiest and best of healthcare services with a smartphone. MEDBOX™ provides services from searching a doctor to online appointment booking, from online medical prescription to healthcare record keeping.

Healthcare industry is expanding very fast in India in terms of revenue and employment but access to effective healthcare is still critical to those in times of need. We talk of

technical advancements in healthcare sector and also that India’s National Health Policy draft 2015 intends to make it a fundamental right. Unfortunately, things don’t seem to be going that way as we see millions of Indians struggle to get good healthcare services every single day.

Today, a good healthcare is not easily accessible and if anyone happens to get it, their experience is not very pleasant or satisfying one.

Healthcare record management is also a painful job for the medical and healthcare institutions as

maintaining the heavy files of reports and prescription, need to be updated every time the patient wants to see a doctor and also the fact that patient reports are hardly analyzed by all doctors which is obviously a very critical as well as tiresome job.

Considering this MEDBOX™ is evolved, a product of b2c digital pvt. ltd., Ahmedabad, Gujarat.

“Our product is sure to bring a revolution in the healthcare industry, and we are working towards making the healthcare process quite accessible and easy for all those

Their services includes searching for the right doctor, finding locations of clinics on map, booking online appointments, store personal medical/health records, search for pharmacies and diagnostic centers according to geo-locations, book lab tests, order medicines by prescription uploading etc.

And the most essential feature being all the medical records can be stored on cloud database which are secured by HIPAA compliant secured servers.

Hence, this is certainly an initiative towards better healthcare experience in rapidly growing digital world aiming to make easier, faster and accessible way to stay healthy.

Medical Device ASIA | September-October 2015 | 41

MEDICA CONNECTED HEALTHCARE FORUM: NETWORKING IN THE FIELD OF HEALTH HAS MANY FACETS

N

etwork connection from hospitals to schools: The topics at the MEDICA CONNECTED HEALTHCARE FORUM go much further beyond what one spontaneously thinks of when the word network is mentioned.

Running on a new set of days from Monday to Thursday, the forum, which is being held in trade hall 15 as part of the world’s largest medical trade fair, MEDICA 2015 (from 16 to 19 November) with around 4,800 exhibitors, covers a wide spectrum of subject-matter, ranging from networked healthcare systems to the Internet of Things, “Wearable Technologies”, all the way to “Medical Apps”.

Right off the bat, two projects deal with young long-term patients, who do not want to, and should not, lose contact to school and their school friends. One of them is

entitled “Avatar Kids”. Within the scope of this Swiss project, the avatar robot “Nao” is the connecting element between school and home and the long-term patient staying in hospital. The connection is established over the Internet. The avatar robot represents the child at school and makes it possible for him or her to be “present” in realtime and participate “live” in school lessons. “Nao is very popular,” explained Jean Christophe Gotanian, CEO of Avatarion Technology. The school children perceive that the absent fellow classmate is present within the robot – and think this is cool most of the time. They can see their fellow classmate via a tablet PC (by Samsung) that has been attached to the head of the movable robot. Thereby, the Avatar robot is not a toy. He is given to the best school friend of the young patient, although it is the teacher that

42 | September-October 2015 | Medical Device ASIA

controls the robot with his own tablet PC. Here, he also sees for example what the young patient is writing in hospital.

Four university hospitals and twenty wards are already taking part in the project. According to Christophe Gostanian, contact has already been made with Italy, Belgium, Holland and France. In Germany, the project will be presented to the professional public for the first time at the MEDICA CONNECTED HEALTHCARE FORUM. Use of the Avatar robot “Nao” should not merely be limited to classrooms. On the one hand, for example, the robots should help to provide the children with information regarding pending interventions.

However, using the device on the robot’s head, the young patient can be “beamed” to the schoolyard via

an Internet connection or be present during a class trip. Furthermore, by means of this, a connection between the family and the child in hospital can naturally become a reality. In particular, this can be important during the evening hours when young patients are alone. In the future, use at retirement homes is also planned – where, for example, “Nao” will ask questions, demonstrate yoga or movement exercises or answer questions about the weather, but would also be able to draw bingo numbers. In any case, the experience made with Avatar Kids seems to be encouraging. Patients between the ages of six and 17 are pleased about the new possibilities and the doctors decide on how much their patients can achieve.

“Smart Cities” project in Hamburg “Some patients get a bad diagnosis

from us. But it is even worse for them if they are totally ripped from their social environment.” This was also described by Professor Christian Gerlofff, deputy medical director and head of the department for Neurology at the HamburgEppendorf University Hospital, (UKE). In a project promoted by Cisco at the children’s hospital of the UKE, children who are ill over the long term are given the opportunity to continue participating in their school lessons using video technology. This project is taking place within the scope of “Smart Cities”, which Cisco and the City of Hamburg are working on in cooperation with each other. Under the heading “School and Health”, this specifically makes it possible for Thorben, who has been ill over the long term, to actively take part in school lessons along with his fellow classmates and teachers via audio and video transmission.

Equipped with an iPad and the video soft client 'JAbber’ installed on it, Thorben can control the camera located on a trolley in his classroom. “We only have to roll the trolley into the classroom in the morning, plug in the power cable

and switch on the power strip.

When Thorben turns on, we hear a quiet noise and know that he is here,” explained Christina Iserhot, Thorben’s school teacher. In fact, Thorben actively takes part in the lessons.

“It was our goal to take children out of their isolation and make it possible for them to actively take part in school lessons. If someone whispers in the background or something falls down, Thorben becomes aware of it and is capable of directing the camera toward it,” explained Till Osswald, business development manager of the healthcare department for the EMEA region at Cisco. In the meantime, the pilot project was expanded to include another student, a 17-yearold grammar school pupil.

“The experience shows that users accept and understand the technology very quickly and immediately feel included again on a social level.” The project has been developed and executed in cooperation with Avodaq, Cisco and the Hamburg-Eppendorf University Hospital. In the meanwhile, there have been fifty registrations on the waiting list from

Hamburg alone.

Particular dynamics in the field of wearables The “Internet of Things” and “Wearables” also have the potential of becoming an essential element of networked health in the future. As part of the MEDICA CONNECTED HEALTHCARE FORUM and the “WT Wearable Technologies Show” (also in the MEDICA hall 15, stand A 23), around thirty companies from the entire supply chain will be showing where things will be heading toward in their opinion. Not only devices will be presented, but also the latest technologies that make these devices possible in the first place.

Christian Stammel, founder and CEO of the WT Wearable Technologies Group, particularly emphasises the sophisticated options provided by data processing, which have made enormous advancements due to wearable technologies such as sensors. That which had originally been worn privately, ranging from quantified self-movement all the way to self-tracking, is going to also increasingly establish itself in the field of healthcare and replace older technologies. The spectrum of devices ranges from lifestyle

products such as the Apple Watch, to intelligent glasses and hearing devices, so-called “hearables”, all the way to the latest trend – intelligent patches that continually retrieve physical data, but that can also administer medications in a minimally evasive manner.

Smart patches on the path to becoming multi-talents In comparison to T-shirts with integrated sensors, the risk of artefacts is, for example, considerably less in the case of smart patches and the products are almost invisible. These “smart patches” could mean a great alleviation in the future, particularly for diabetics. As an example, Stammel mentions the “Diabetes Care’s FreeStyle Libre”, which has been approved by the FDA. European approval is still pending, but: This is a patch for measuring blood sugar that can be worn while showering, swimming and when doing sport and only has to be changed every two weeks. By means of a painless scan, the patient obtains the current glucose value, the glucose data over the course of the last eight hours and trend

Medical Device ASIA | September-October 2015 | 43

information concerning where the glucose value is heading. As another example for the usefulness of smart patches, Christian Stammel mentions “UpRight”, which monitors body posture while it is worn on the back. The product belongs to the generation of “trainables”; it triggers an alarm if body posture is wrong and helps to correct it. This indicates a new trend: The continuous correction of poor posture by means of the devices.

At the MEDICA CONNECTED HEALTHCARE FORUM, co-exhibitors of the Wearable Technologies joint stand will be presenting the new intelligent patches, Feeligreen and RootiLabs for example.

reference value, providing a basis for consultation and, maybe, this data will also contribute to making a diagnosis or finding a therapy.

Qardio is a good example for this.

At the MEDICA CONNECTED HEALTHCARE FORUM and at the Wearable Technologies joint stand, the company will be presenting products for measuring blood pressure and ECGs, among other things. The devices are supposed to be very user-friendly and, having an appealing design, be able to be perfectly integrated into everyday routine.

What should be done if patients collect data on their own?

Wearable technologies can also provide support in hospitals for optimising processes and organisation. For example, they can help in avoiding decubitus. Using sensors, it is detected if patients have been moved or not and can serve hospital personnel as a memory aid. Christian Stammel emphasises: “Today, many existing technologies already available can be used without taking any major measures with regard to infrastructure.”

Another tendency to be taken seriously is that physicians are increasingly confronted with data that originate from devices that have not been certified for the medical field. Christian Stammel is quite sure that these products provide reliable data. “Physicians should not simply disregard this data as irrelevant.”

Data that is collected by patients and brought to the attention of their physicians can provide at least a

Clinical applications for wearables are also thinkable

He does not see future challenges in the technical field. The technology

44 | September-October 2015 | Medical Device ASIA

is available. In fact, Stammel sees the difficulty of making progress in developing practical applications, algorithms and data analyses. He noted that sensors, which are already being used in smart watches, are not used enough. In particular, Stammel sees a forwardlooking trend concerning the change and observation of behaviour patterns by means of mobile devices. In particular, on Monday, 16 November and Wednesday, 18 November, the MEDICA CONNECTED HEALTHCARE FORUM is offering the possibility for hospitals and physicians to gather information on the latest developments.

Thereby, Wearable Technologies will not only be presenting new devices, but also other important elements belonging to the supply chain. Markus Sieber from TÜV SÜD Produkt Service GmbH, for example, is going to be covering the testing of wearables as medical devices.

And let’s get to apps - at the MEDICA App COMPETITION On Tuesday, 17 November 2015, at the MEDICA App COMPETITION, it is all about the best medical app for professional use within the scope of the everyday routine of doctors and

in hospitals. Thereby, the consumer market of fitness and wellness apps is explicitly not being focused on, according to the organiser, Mark Wächter, chairman of MobileMonday Germany. From 10 August to 10 October 2015, app developers from the entire world can submit their medical apps to participate in the competition. These submissions are pre-selected by the MEDICA expert team. Ten developer teams will be able to qualify for participation at the live pitch taking place at the MEDICA. During the MEDICA 2015, all medical apps nominated will be presented on stage in hall 15, and afterwards, the winner will be selected on site by a top-class jury.

Thereby, in addition to user friendliness, criteria will particularly be the business model and the contribution to process optimisation and increasing efficiency.

In the previous year, “Medopad”, a suite of iPad applications won the competition, which makes it possible to add captured health data to existing databases and make them available on tablets.

All information on MEDICA 2015 and on the programme of the integrated forums, such as the MEDICA CONNECTED HEALTHCARE FORUM, for example, is available online at: http://www.medica.de

SIEMENS ADDS THREE NEW HEMATOLOGY SYSTEMS TO ITS PORTFOLIO OF SCALABLE SOLUTIONS IN INDIA capacity of 100,000 results. Also, two scattergrams and two histograms per result help aid interpreting disease-state information. The ADVIA 560 AL System offers automatic sampling with an optional autoloader that simply plugs into the side of the system for even greater workflow efficiency and true “walkaway” capability.

For further information about Siemens entire family of scalable hematology systems, please visit http:// www.healthcare.siemens.com/ hematology. Introducing ADVIA 360 System, ADVIA 560 System, and ADVIA 560 AL System offering state-of-theart hematology testing High quality complete blood count testing, running up to 60 samples per hour Designed for small to mid-sized laboratories and hospitals The ADVIA 360 System measures 22 parameters, including a 3-part white cell differential and storage capacity of 10,000 results The ADVIA 560 System and ADVIA 560 AL System measure 26 parameters, including a 5-part white blood cell differential and storage capacity of 100,000 results

S

iemens Healthcare launches three new scalable hematol ogy systems: the ADVIA 360 System, ADVIA 560 System and ADVIA 560 AL System. Owing to the different laboratory sizes and varied testing environments, there is a need for accurate results, streamlined workflow and easy-to-use automated processes. To cater to this demand, Siemens has broadened

its spectrum of hematology solutions by introducing these systems. These lower capacity systems offer state-of-the-art hematology testing capabilities for small to mid-sized laboratories and can also be used as back-up systems for larger diagnostic setups.

“We are proud to expand our family of scalable hematology analyzers with flexible and intuitive options to suit the demographic requirements of different laboratories in India.

Siemens’ scalable options have been designed to meet the needs of our customers by giving accurate, reliable, easy-to-use and costefficient hematology solutions for different testing volumes.” says Mr. Richard Guest, CEO, Siemens Healthcare, India.

The systems offer fast, high quality CBC testing, running up to 60 samples per hour. Engineered for safety and ease-of-operation, the new ADVIA hematology systems help optimize and manage workflow through several convenient features, such as the choice of open- or closed-tube sampling and customizable result printing.

Automatic anti-clogging and cleaning procedures are employed to ensure results reliability. Along with automated maintenance, this reduces manual procedures and biohazard exposure. Other features include: the option for manual or automatic calibration procedures, a cap-piercing function for accurate and safer sampling, a multilingual operating menu and bidirectional LIS communication for easy patient data transfer between laboratories and minimized paper-based work lists.

With a compact footprint, the ADVIA 360 System allows smaller laboratories to efficiently generate reliable and accurate results while conserving precious benchtop space. This system provides a threepart white cell differential and storage capacity for 10,000 results.

An integrated ticket printer streamlines results reporting.

The ADVIA 560 System can serve as the primary hematology analyzer in small to mid-sized laboratories and as a backup for the company’s ADVIA 2120i System in larger laboratories. It provides a five-part white cell differential and storage

Siemens is a technology powerhouse that has stood for engineering excellence, innovation, quality and reliability. The company focuses on the areas of electrification, automation and digitalization.

It is one of the leading producers of energy-efficient, resource-saving technologies; combined cycle turbines for power generation; and power transmission solutions.

Siemens is a pioneer in infrastructure solutions and automation and software solutions for industry.

The company is also a leading supplier of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. At the end of September 2014, Siemens India had around 18,500 employees, 23 manufacturing plants and a nation-wide sales and service network. Siemens Limited, in which Siemens AG holds 75% of the capital, is the flagship listed company of Siemens AG in India.

Further information, please visit: www.siemens.co.in

Medical Device Asia | September-October 2015 | 45

INTERNATIONAL SHOWCASE OF LATEST TECHNOLOGIES AT

Manufacturing Myanmar 2015 to Lift Local Manufacturing Sector

A

strong projection for Myanmar’s economic growth this year coupled with the launch of the ASEAN Economic Community are set to increase opportunities for the local manufacturing industry. These factors, as well as the Free Trade Agreements Myanmar has signed individually and as part of ASEAN, with countries and regions such as Australia, China, India, Japan, Korea, New Zealand and the United States, will bring upon more trade activities, as well as foreign investment into the country.

To compete, it is crucial for companies in the sector to invest and update their technologies.

Manufacturing Myanmar 2015 will be highlighting the latest technologies from around the world that will help manufacturers enhance their productivity and efficiency. More than 60 exhibitors from 13 countries and regions will be participating in the event’s second edition, to be held at Myanmar Event Park from 15 to 17 October 2015.

Exhibitors will be showcasing their bestselling technologies for the international market, as well as manufacturing equipment and solutions that are new to Myanmar.

Boosting opportunities for manufacturing sector through conducive business networking platform As Myanmar continues on its economic journey to attract foreign investors, the need to quickly increase productivity and improve efficiency in the manufacturing sector becomes more important.

Speaking of this need at a press conference today, U Aye Tun, Vice President of the Myanmar Industries Association, was delighted at the

wide range of manufacturing solutions offered and representation of international brand names at Manufacturing Myanmar 2015.

“The business opportunities for local manufacturers will continue to increase and it is important for them to capitalise on these by shoring up their capabilities. Investing and updating the technologies will certainly help Myanmar’s budding manufacturing sector provide even more viable and effective services to the international companies that are investing in the country. Manufacturing Myanmar, in this respect, has set the highest standard possible and I am glad that they have continued to provide a conducive and viable business networking platform to connect local manufacturers with the global market,” says U Aye Tun. Myanmar Engineering Society’s President, U Win Khaing adds, “We are excited with the level of technology and knowledge that Manufacturing Myanmar will be presenting. This is an excellent opportunity for local industry professionals to network with international experts and industry professionals and address gaps in knowledge and skills. Through the event, manufacturers will also be able to avail the latest technologies on the market and enhance their skills to meet the requirements of international companies.”

Also present at the press conference was Mr. Max Myint, Marketing Director of Summit Goal, a leading importer and distributor of construction tools in the Myanmar market and first-time exhibitor at Manufacturing Myanmar 2015. The company has been at the forefront of technology and will be presenting bestselling welding and metal cutting technologies from the region

46 | September-October 2015 | Medical Device ASIA

at the event.

Commenting on the growth of the manufacturing industry, Mr. Myint says, “Over the past few years, we have seen more and more foreign companies coming into Myanmar to set up operations and the need for local companies to improve their hardware, so that they can provide a broader variety and better services for these international companies.

We have been introducing the latest tools and technologies to the Myanmar market over the years.

Participating in Manufacturing Myanmar is the perfect platform for us, as we will be showcasing some bestselling products from the region, and we will also build on the opportunities to explore collaboration with other regional and international companies.”

Strong international presence at Manufacturing Myanmar 2015 There will be four international group pavilions from Germany, Korea, Singapore and Taiwan, led by various associations such as the Incheon Business Agency for Korea, Singapore Precision Engineering and Technology Association for Singapore and Taiwan Machine Tool & Accessory Builders’ Association for Taiwan.

Exhibitors will be showcasing their countries’ capabilities and technologies catered for the local market.

Notable companies exhibiting for the first time in the international group pavilions include, but not limited to: In addition to the four international group pavilions, individual exhibitors from Asia and Europe such as India, Italy, Japan, Korea, Malaysia, Myanmar, Thailand, United Kingdom and many others will also be participating. They include Deep Tools, Enomoto, Hitachi, Pye Tools,

See Hau Global, Saint Gobain, Summit Goal, Tochu, Yawata and more who are making their first foray into the Myanmar market. Returning exhibitors include Assurich Industries, Benign Enterprise, Chii Long Iron Works, Hup Hong Machinery, MG SRL, Olympus, Optical Gaging, Sky Mahar, TRUMPF, Volkel and YG-1 Tools Asia.

Mr. William Lim, Project Director for Machinery Events, from organiser Singapore Exhibition Services says, “Manufacturing Myanmar is focused on bringing in the best and most updated manufacturing equipment, solutions and services to the country. More than 90 per cent of our exhibitors are from overseas, and many of them are venturing into Myanmar for the first time. They have been following on developments in the manufacturing sector closely and are eager to share their knowledge and expertise with local manufacturers.”

Manufacturing Myanmar 2015 will be co-located with Oil & Gas Myanmar 2015, the largest oil & gas event for industry professionals to congregate and source for a myriad of international oil and gas suppliers and service providers.

About Singapore Exhibition Services Pte Ltd Singapore Exhibitions Services organises a portfolio of international tradeshows serving the Communications, Engineering, Machinery and Lifestyle industries. Its events consistently attract a high level of overseas participation with foreign exhibitors accounting for almost 80% of the show floor. Singapore Exhibitions Services is a member of Allworld Exhibitions Alliance, a global network with over 50 offices worldwide. For more information, please visit www.sesallworld.com

Medical Device ASIA | September-October 2015 | 47

Siemens solutions support diagnosis and treatment of cardiovascular diseases New cardiovascular imaging and information system drives care outcomes Real-time 3D echocardiography offers major advantages in clinical practice Stents can be accurately positioned even during complex interventions Four-minute cardiac imaging with latest SPECT system

C

ardiovascular diseases such as heart attack, stroke, and coronary heart disease have been among the most common causes of death worldwide for many years now. Advances in medical imaging play a key role in the fight against these diseases by helping achieve sound diagnoses even at earlier stages and enabling efficient interventional therapy. At this year’s Congress of the

European Society of Cardiology (ESC) in London, United Kingdom, Siemens Healthcare is presenting innovative IT solutions and medical imaging systems in the areas of angiography, ultrasound, magnetic resonance tomography, and computed tomography, with the theme of “More cardiology, less heartache.” These are intended to help physicians diagnose cardiovascular diseases at an early stage, structure treatments to best suit the individual patient, and perform interventions safely.

New cardiovascular imaging and information system drives care outcomes Growing cost pressure on hospitals increases the need for cardiologists to streamline their work processes. This is why Siemens has refined its tried and tested Syngo Dynamics cardiovascular information

48 | September-October 2015 | Medical Device ASIA

system (CVIS) to not only help diagnose cardiovascular diseases but also to reduce the administrative load on medical staff and provide the best possible support in outcome-focused management decisions. The main focuses for improvement were on reading and reporting capabilities as well as interoperability and integration into other systems, such as the electronic health record (EHR) system. Data exchange between disparate systems makes improved efficiency and care outcomes possible. This interoperability gives various departments within a hospital – and multiple hospitals within an enterprise– a single point of access to relevant cardiovascular information. For example, specific echocardiography data such as ejection fraction heart failure measurements can now be

included more easily and at earlier stages for therapy or medication planning.

While an examination is in progress or during interventions, multimodality clinical images and measurement data can be transferred directly into Syngo Dynamics, which reduces the risk of error compared with manual data input.

Unusual results are now automatically highlighted, too, to direct attention to potential pathologies.

When results or reports are being drawn up, the system also automatically reviews data plausibility1 as a means of drawing attention to any potential missing or erroneous entries. This speeds up the accurate documentation of patient flow within the hospital, which in turn saves time and reduces costs.

Real-time 3D echocardiography

helps personalize treatments In order for physicians to optimally plan and perform surgical and minimally invasive cardiac procedures, the information they obtain about the patient’s heart must be as accurate as possible. With the Prime edition of its Acuson SC2000 premium cardiovascular ultrasound system, Siemens combines two state-of-the-art technologies: A transesophegeal echocardiography (TEE) probe, which is guided into the patient’s esophagus, provides detailed real-time 3D color Doppler images of the heart anatomy and blood flow and the eSie Valves analysis software, which automatically measures individual heart valves in just seconds – much faster than any software currently on the market.

Imaging the heart in real-time makes it easier to examine and treat patients. Current imaging methods that use 3D TEE require stitching, which means combining multiple heartbeats on the computer and calculating cardiac function and blood flow from consecutive

cardiac cycles. This approach can lead to potentially misleading image artifacts, especially with patients with arrhythmia. The Siemens technology has been available on the European market since June and has proven successful in clinical practice. “It really makes a difference when you can see complete anatomy and blood flow at high volume rates with Siemens realtime 3D TEE. It enables you to perform valve procedures with more accuracy and more confidence, potentially improving patient safety and outcomes. It is truly a step forward in technology,” says cardiology Professor Stéphane Lafitte, Hôpital Cardiologique CHU in Bordeaux, France.

Stabilizing heart movements allow stents to be perfectly positioned Many patients cannot undergo open heart surgery because of their age or health issues. That’s why minimally invasive therapies have developed into a valuable treatment alternative and have now become part of the

clinical routine.

One example is the use of percutaneous coronary intervention (PCI) in significant coronary stenoses, which involves balloon angioplasty to restore normal coronary blood flow.

To keep the revascularized segments open permanently, cardiologists must position coronary stents or scaffolds (bioresorbable coronary stents) during PCI with absolute accuracy despite the movement of the beating heart.

The Clearstent Live application, which is now available for all new Siemens angiography systems, virtually reduces heart movements during interventions, stabilizing the area around the balloon catheter.

This gives the cardiologist a clear view of the stent, enabling it to be perfectly positioned – even in particularly challenging locations such as bifurcations.

To treat longer lesions, cardiologists sometimes have to place several stents in a row with accuracy down

to the last millimeter, because gaps could lead to restenosis or even heart attack. The use of thinner and thinner stents or x-ray transparent scaffolds makes visibility worse. For example, the fine platinum markers on scaffolds may be barely identifiable in angiography systems, but with Clearstent Live it is much easier to position them directly against each other, thanks to reduced movement. “With the help of Clearstent Live, I now see the stent at all times in excellent detail.

That makes life much easier,” says Professor Christoph Kaiser, MD, Head of International Cardiology at Basel University Hospital, Switzerland.

New SPECT system enables fourminute cardiac imaging Siemens’ latest SPECT system Symbia Evo is designed to significantly increase productivity and offers the potential to double patient throughput compared with conventional SPECT systems: for example, by automating routine

Medical Device Asia | September-October 2015 | 49

manual tasks. Nuclear cardiologists who use the new system can increase efficiency through a fourfold reduction in scan time with IQ-SPECT cardiac imaging technology. While routine SPECT cardiac acquisitions typically take about 16 minutes and risk patient movement that may result in lower image quality, a field-upgradeable hardware and software combination of Symbia Evo and IQ-SPECT enables a reduction in imaging time to four minutes with a standard dose, or up to 75 per cent lower injected dose for imaging in standard time.

cardiologists physical quantity measurements of the characteristics of heart muscle tissue. The application quantifies even the smallest changes in heart muscle tissue and displays them on an image in color. This is especially helpful in the case of heart diseases that involve minimal tissue lesions that are distributed across the entire heart – for instance, scar tissue and edemas. Physicians can now make valid diagnostic and treatment decisions even earlier than was previously possible and adapt the method of treatment more quickly if necessary.

Easier tissue differentiation using MRI now available to even more customers

Many more customers can now make use of tissue quantification using MyoMaps. Whereas the application was previously limited as a standard feature to Siemens’ two premium MRI systems – the Magnetom Skyra 3-Tesla scanner and the Magnetom Aera 1.5-Tesla scanner – it is now also available on the Magnetom Amira 1.5-Tesla scanner, which was introduced at RSNA 2014. MyoMaps is also

Magnetic resonance imaging of the heart, or “cardiac MRI” for short, supplies detailed information about the myocardial perfusion, morphology, and function of the heart with no radiation exposure. Beyond a visual diagnosis, the MRI application MyoMaps from Siemens gives

50 | September-October 2015 | Medical Device ASIA

available via scanner upgrades on the current software platform Syngo MR E11.

A cardiac CT in a quarter of a second Computed tomography of the heart has supported huge advances in the past decade and lends itself very well to the task of rapid diagnostic evaluation of the coronary arteries.

The dual-source technology used in the current Somatom Force highend system is what makes the fastest imaging speed on the CT market possible: A cardiac dataset can be acquired in just a quarter of a second.

This means that patients require beta blockers less often to slow their heart rate in order to avoid movement artifacts. It is also not necessary for them to hold their breath thanks to the fast acquisition speed of 737 millimeters per second and high temporal resolution of 66 milliseconds.

In addition, a significantly lower x-ray dose is needed compared with existing premium CT systems. CT angiography benefits in particular from the fact that, with the optimized Care kV technology of the Somatom Force, the tube voltage can be flexibly set between 70 and 150 kilovolts (kV) and more patients can now be scanned with lowvoltage values.

When examining obese patients at 70 or 80 kV, this can result in a dose reduction of 68 percent over traditional 120-kV protocols. As a result, the system’s high scanning speed combined with a lower radiation dose opens up new possibilities: for example, extending the use of CT scanning to the early detection of coronary heart disease.

The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed.

Further details are available from the local Siemens organizations.

COMPAMED 2015: The medical technology miniaturising trend marching on – suppliers are offering solutions for various applications Reality in the future? Nano-robots as a medical transport unit for penetrating into tumours

T

he success of the COMPAMED can be explained as the result of closely integrating development processes on the part of the suppliers as well as on the part of their customers,” said Joachim Schäfer, managing director of Messe Düsseldorf, explaining in a nutshell why, in addition to visiting the world’s largest medical trade fair, MEDICA, also visiting the internationally leading trade fair for the supplier market of medical technology represents an opportunity to view into future and look at current trends with regard to medical technology innovations. Always scoring top annual results in reference to the number of exhibitors and visitors, COMPAMED has long since developed into the leading international marketing communication platform for suppliers

of the medical technology industry.

For the first time, the COMPAMED will be held at the very same time as the MEDICA from 16 to 19 November 2015. To date, COMPAMED has always ended a day earlier. From this year on, it will also be new that the trade fair will be running on the weekdays from Monday to Thursday.

The added time for discussions with your customers from the medical technology industry, namely a substantial number of around 4,500 MEDICA trade fair exhibitors, should be very much in line with the, once again, more than 700 exhibitors of the COMPAMED (in trade fair halls 8a

and 8b). This is because the market for medical technology and medical products is very dynamic. The innovation cycle is considerably shorter than is the case in other industries. In the process, the development competence of the suppliers, in part, is often the point of origin for ground-breaking innovations with regard to efficient and effective medical care.

For example, this also applies to further increases in the level of miniaturisation. An especially extraordinary example, which currently brings science fiction to mind, entails nano-robots in the bloodstream that autonomously

Medical Device Asia | September-October 2015 | 51

carry out operations. Corresponding with these ideas, the Max-Planck Institute (MPI) for Intelligent Systems (Stuttgart) have developed two different micro-swimmers. Thereby, on the one hand, it has to do with a type of clam that moves forward by opening and closing as well as a screw that moves forward by means of rotation. Its diameter is only 100 nanometres; its length 400 nanometres. A rotating magnetic field that is applied externally sets the mini-screw into motion. The manufacturing process for the special swimmers is 3D printing, which is increasingly gaining in significance for a wide variety of applications at the COMPAMED. All materials used, such as polydimethylsiloxane, are biocompatible and body compatible. Researchers imagine that, one day, nano-robots will introduce tumour therapeutic agents directly into the tumour. “Theoretically, at the size of our construction, application within the cell would be conceivable,” explained Peer Fischer, head of the working group Micro-, Nano-

and Molecular systems at MPI for Intelligent Systems. In any case, the mini devices should contribute to making interventions minimally invasive, improve their effectiveness and shorten the times spans required for such interventions.

However, a series of years may go by until this science fiction becomes a reality.

SMALL BUT IMPRESSIVE AND WITH THE HIGHEST LEVEL OF PRECISION In the meantime, many “mini” solutions have now already become a reality since the demand for increasingly smaller systems remains constant in the field of medical technology. “The life-science industry is showing an increased demand for the miniaturisation, micro-structuring and an integration of optical and electrical functions in inexpensive components,” confirmed Peter Kirkegaard, CEO of IMT Masken und Teilungen AG from Switzerland. IMT addresses this need using manufacturing technologies deriving from the semiconduc-

52 | September-October 2015 | Medical Device ASIA

tor industry. Based upon glass, the company manufactures microchannels, clearance holes, electrodes, optical and electrical coatings, waveguides and grating – the smallest structures have tiny dimensions down to only 150 nanometres. Their fields of application include lab-on-a-chip systems, among other things. Micreon GmbH also acts as a contract manufacturer – the company is among the worldrenowned specialists for micro processing using ultrashort pulse lasers within the pico and femto range.

The laser is playing an increasingly important role in manufacturing medical implants, instruments or measurement devices in the field of medical technology. Since the highest level of precision and quality is required in the case of medical products, especially for the ultrashort pulse laser technique, an increasing number of application possibilities are arising. An example includes vessel wall supports (stents) made of organic materials.

Since the bio-resorbable polymers

are very sensitive to temperature, the femtosecond laser is the only tool used for manufacturing refined and structured components without any damage.

RECORD PARTICIPATION AT THE IVAM JOINT STAND IMT und Micreon are being represented along with around another 50 exhibitors at the joint stand of the IVAM professional association for micro-technology, which will once again be forming a focus for microsystem technology, nanotechnologies, production technology and process control in hall 8a.

“This is a new record; our floorspace comprises almost 700 square metres,” explained Mona Okroy-Hellweg, speaker for the IVAM. Also this year, the professional association is organising the COMPAMED HIGH-TECH FORUM (Halle 8a). Along with the VTT Technical Research Centre of Finland, one symposium deals with the topic that is gaining an increasingly

important role, also in the field of medical technology: Printed electronics. In addition, the topic of this year’s spring forum “Lasers – Optics – Photonics” will be focussed on during a symposium.

“Since many sensor manufacturers are represented at our stand, we additionally work on a session on the topic of “Smart Sensor Solutions,” said Okroy-Hellweg.

The COMPAMED SUPPLIERS FORUM is taking place in parallel again in hall 8b, which is traditionally being organised by the trade magazine DeviceMed. The focus of numerous presentations by specialist from internationally leading companies entails current development along the entire process chain.

“On all four days of the trade fair, exhibitors will be providing information on technical innovations and further topics within the scope of the interplay between manufacturers, suppliers and physicians or users. Beginning with innovative materials as a basis of many new technical innovations to the usercentred design of medical technological applications according to IEC 62366 and miniaturisation system, the entire process chain is represented, all the way to the topics of packaging, market access and approval,” reported Peter Reinhardt, editor in chief at DeviceMed.

trend. In this connection, as a joint effort since April 2015, the Fraunhofer Institute for Electronic Nanosystems ENAS, which has been represented at the COMPAMED several times already, the Saxon company, EDC Electronic Design Chemnitz GmbH, and the Canadian company, Preciseley Microtechnology Corporation, have developed a micro-opto-electromechanical system (MOEMS) for optical coherence tomography (OCT). The envisaged solution should make high-resolution in-vivo OCT diagnostics possible.

the tissue structures. In relation to rival techniques, the advantage entails a high level of penetration depth into the tissue with a high level of resolution. In contrast to sonography, OCT is not based on an acoustical method, but on optical interferometry (distance measurement) instead. The joint project has been made possible by an initiative of Alberta’s ministry for higher education (EAE) and the Federal Ministry for Economy and Technology (BMWI).

When miniaturising the design, increasing the precision of the OCT method can only be achieved at the same time by implementing integrated piezoelectric sensors and an application specific integrated regulation circuit. By means of this, it is possible to integrate highprecision coherence tomographic images into an endoscope and obtain non-invasive three-dimensional images of tissues structures.

OCT is used in a variety of medical fields, such as ophthalmology for example.

A “never-ending hot topic” at the COMPAMED entails coatings, especially those with antimicrobial action. Biofilms on catheters can lead to infection in patients.

Therefore, in the USA, already two thirds of all catheters on the market have antimicrobial coatings and/or antithrombogenic coatings. Even if different legislation prevails in Europe, in the meanwhile, such catheters are also used here. Using the so-called “non-leaching method” the supplier, Cikautxo, located in northern Spain, has developed catheters with a surface treated with a substance that kills off bacteria at the moment the bacteria come into proximity of it. Using this method, no substances are released into the vascular system so that no side effects result. Cikautxo works

The condition and possible diseases of the retina can be detected by means of non-invasive OCT examinations. Using OCT, it is possible to obtain three-dimensional images of the composition of

Coatings that can kill off bacteria

with an antimicrobial coating made of polymers and their antithrombogenic effect, which is based on heparin.

Once again, the upcoming COMPAMED will give an overview of the entire range of medical technology suppliers. The range of offers for visitors spans from tiny sensors all the way to packaging machines that fill entire rooms, from innovative materials to refined microsystems, from mobile diagnostic devices all the way to electronic manufacturing services (EMS). In the future, 3D printing should also become a focus at the COMPAMED. According to a survey carried out by DeviceMed, 31 percent of the companies questioned already rely on the innovative method; 35 percent are planning to use it in the foreseeable future. Only one third of the approximately 80 companies recorded up until this point do not currently see any possibilities for its application. Also from this point of view, a visit to halls 8a and 8b are certainly worthwhile this year, being the first time for exciting discussions and business to take place for a day longer.

Dates of the COMPAMED + MEDICA 2015: 16 – 19 November

This year, presentations on delivery performance in the fields of medical technology, including presenting tools and parameters for improved performance are new. The “Innovation Guide”, initiated by the Federal Ministry for Education and Research, is also a topic. It accompanies innovation processes step by step along the individual stages of innovation, research – development – certification – reimbursement – market. The programme will be rounded off by practical instructions on how to protect innovations as well as on IT security.

HIGH-TECH FOR THREE-DIMENSIONAL IMAGES OF TISSUE STRUCTURES Furthermore, optical techniques for improved diagnostics are currently in Medical Device Asia | September-October 2015 | 53

Transasia opens new vistas at the 8th Medical Technology Conference of Confederation of Indian Industries (CII)

T

ransasia Bio-Medicals Ltd. has been providing accurate, reliable and affordable diagnostic solutions for over thirty five years now.

‘Make in India for the World’ has been Transasia’s credo all along.

With its total solutions in Clinical Diagnosis, Transasia has spread its global footprints, serving millions across hundred countries. The ERBA-Transasia Group has been at the forefront of engineering and crafting indigenous products and solutions of international standards.

Medical Technology Conference is the annual flagship event of Confederation of Indian Industry (CII). The 8th edition of the conference was recently held at New Delhi on 28th August, 2015.

The event saw the congregation of the best names driving the Indian healthcare industry. The apt theme ‘A $50 Billion Medical Technology Industry: Making it Happen in India’ set forth a platform for a plethora of ideas and opportunities!

Mr. Suresh Vazirani, Chairman & Managing Director, ERBA-Transasia Group addressed the delegates on ‘Making India a Manufacturing and Export Hub- translating dreams into

reality’. A strong apostle of the Make in India ideology, he advocated the need for indigenous manufacturing of healthcare products. While highlighting that the Indian healthcare market is on an upward growth track, Mr. Vazirani remarked, “Indigenous manufacturing is picking pace. At one point of time, the ratio of indigenous manufacturing to imports was just 5%.

However, tables have turned today.

A lot many companies are now involved with in-house manufacturing. Indian companies have been manufacturing kits for blood grouping, serology, clinical chemistry, pregnancy detection, HIV detection and other Rapid tests that are accepted globally. Today, imports of such products are negligible in finished form.”

He further added that, “Today, the diagnostic business is mainly based on technology. The drive or thrust for smaller, faster and easily accessible devices is increasing.

Emerging markets have different needs with respect to test menus, technologies and operating procedures. Thus customized solutions need to be developed depending on the need. Indian

54 | September-October 2015 | Medical Device ASIA

companies with their R&D facilities have developed a range of good quality products for the local market amidst fierce competition.”

On speaking of steps to be taken to further boost innovation, he said “Though the Government has introduced a lot of policies for inhouse production, there is still scope for more. The government and private players need to join hands to promote innovation at reasonable prices.

The Government needs to initiate policies to encourage indigenous manufacturing. This can be done through availability of funds, land demarked for setting up manufacturing units, tax relaxation, encouraging research & development, etc.

Encouraging foreign players to set up manufacturing units in India can help further.”

Mr. Vazirani alongwith the other honchos of the industry offered useful insights to place India as a world leader on the global healthcare map.

Mr. Sudhanshu Pandey, Joint Secretary, Ministry of Commerce, Government of India, graced the occasion and underscored the

need for enhancing the medical device industry.

He referred to the new legislation that is being brought about to regulate and harmonize the segment, which is presently covered by the Drugs and Cosmetics Act. Mr. Pandey said, “Since the legislation might take some time, certain short term measures also can be bought to address the immediate problems of the industry such as labeling requirements, etc.”

He called the transfer of technology to give a leg up to the medical device industry by taking up contract designing, research leading to manufacturing. He also referred to better brand building of Indian medical device products to command higher prices in the international market. Products sourced from India at cheaper prices are sold at higher prices abroad, denying the Indian industry the benefits.

On a closing note, Mr. Pandey exhorted industry to evolve a pragmatic pricing policy for equipment. Product pricing should be transparent, predictable and economical to make the medical treatment affordable to the common man.

India’s First Ever Exclusive Exhibition & Conference on Rehabilitation Products & Services An unique event which would bring together all relevant stakeholders - manufacturers, suppliers, traders, physiotherapists, orthopaedicians, home care specialists, rehabilitation experts, pain management professionals, podiatrists, orthotic & prosthetics professionals, NGO’s and end-users.

Key Features A wide range of products & services, all under one roof.

A three days Fellowship Certification Programme by LASHS A dedicated workshop on Occupational Therapy by internationally renowned Dr Erna Blanche, from University of South California.

A focused workshop on CSR Projects for Empowerment of Disabled.

Best opportunity to interact directly with both hardcore rehab professionals & end-users.

A value proposition to enhance corporate image and build brand recognition.

For more details, contact : Japesh Thakur +91 9599389544 japesh@infinityexpo.in

Government of India, Registrar of Newspapers of India (RNI)#: DELENG/2009/30008